| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calcium ion binding | TBC1D9B FSCB TBC1D9 C2CD5 FAT2 BNIP2 PLCB3 SPARCL1 PCDH10 SYT13 NOTCH3 CACNA1E HSPG2 FAT4 PCDHGB2 PCDHGA10 PCLO ITSN1 PCDHB4 CASR PCDHA5 PCDHA3 SELENON VCAN CABS1 DCHS1 MACF1 PLCH1 ATP2B2 | 2.05e-07 | 749 | 262 | 29 | GO:0005509 |
| GeneOntologyMolecularFunction | P-type calcium transporter activity | 8.89e-06 | 11 | 262 | 4 | GO:0005388 | |
| GeneOntologyMolecularFunction | GTPase activator activity | TBC1D9B SH3BP1 FAM13B TBC1D9 BNIP2 PLXNB1 GARNL3 RALGAPB ARHGEF12 ALS2 ARAP3 DEPDC5 SMCR8 | 8.65e-05 | 279 | 262 | 13 | GO:0005096 |
| GeneOntologyBiologicalProcess | regulation of brain-derived neurotrophic factor-activated receptor activity | 2.47e-08 | 4 | 260 | 4 | GO:0031551 | |
| GeneOntologyBiologicalProcess | negative regulation of brain-derived neurotrophic factor receptor signaling pathway | 1.22e-07 | 5 | 260 | 4 | GO:0031549 | |
| GeneOntologyBiologicalProcess | regulation of brain-derived neurotrophic factor receptor signaling pathway | 8.38e-07 | 7 | 260 | 4 | GO:0031548 | |
| GeneOntologyBiologicalProcess | microtubule-based process | MAP1A MAP1B MCIDAS ASH1L NCKAP5 CFAP54 BNIP2 SLC22A14 CFAP45 PKD1 HOOK2 CEP97 WDR72 CACNA1E FLNA CAMSAP3 APC CFAP43 SIRT1 DNAH1 SETD2 RNF4 NISCH CABS1 SENP6 MACF1 ROCK1 CFAP61 DNAAF1 ANKFN1 ATP2B4 USP33 | 4.23e-06 | 1058 | 260 | 32 | GO:0007017 |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | DSCAML1 FAT2 PKD1 PCDH10 FAT4 SDK2 PCDHGB2 PCDHGA10 PCDHB4 PCDHA5 PCDHA3 DCHS1 | 4.73e-06 | 187 | 260 | 12 | GO:0007156 |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | DSCAML1 FAT2 PKD1 SPARCL1 PCDH10 CX3CL1 FAT4 SDK2 PCDHGB2 PCDHGA10 PCDHB4 PCDHA5 PCDHA3 DCHS1 MDGA1 | 1.13e-05 | 313 | 260 | 15 | GO:0098742 |
| GeneOntologyBiologicalProcess | brain-derived neurotrophic factor receptor signaling pathway | 2.24e-05 | 14 | 260 | 4 | GO:0031547 | |
| GeneOntologyBiologicalProcess | regulation of microtubule-based process | MAP1A MAP1B CFAP45 PKD1 CEP97 CAMSAP3 APC CFAP43 SIRT1 RNF4 SENP6 MACF1 ROCK1 DNAAF1 | 2.28e-05 | 293 | 260 | 14 | GO:0032886 |
| GeneOntologyBiologicalProcess | regulation of cardiac conduction | 2.84e-05 | 29 | 260 | 5 | GO:1903779 | |
| GeneOntologyBiologicalProcess | cardiac conduction | 3.92e-05 | 100 | 260 | 8 | GO:0061337 | |
| GeneOntologyBiologicalProcess | cell junction organization | MAP1B SH3BP1 MPDZ PTK2B TJP2 PKP2 SPARCL1 ADGRF1 CX3CL1 PLXNB1 FLNA CACNB4 SDK2 FN1 ANK2 PCLO ITSN1 CAMSAP3 PCDHB4 APC ALS2 LSR PLXNA4 MACF1 ROCK1 MDGA1 ATP2B2 NPAS4 | 4.34e-05 | 974 | 260 | 28 | GO:0034330 |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | MAP1A MAP1B MCIDAS NCKAP5 BNIP2 PKD1 HOOK2 CEP97 WDR72 FLNA CAMSAP3 APC CFAP43 SIRT1 DNAH1 SETD2 RNF4 NISCH SENP6 ROCK1 DNAAF1 ANKFN1 USP33 | 4.50e-05 | 720 | 260 | 23 | GO:0000226 |
| GeneOntologyBiologicalProcess | protein localization to plasma membrane | GPR179 C2CD5 SCO1 PKP2 WDR72 FLNA ANK2 PKDCC ZDHHC7 DCHS1 MACF1 ROCK1 GGA1 ATP2B4 | 6.82e-05 | 324 | 260 | 14 | GO:0072659 |
| GeneOntologyBiologicalProcess | cell junction assembly | MAP1B SH3BP1 MPDZ PTK2B PKP2 ADGRF1 PLXNB1 SDK2 FN1 ANK2 PCLO CAMSAP3 PCDHB4 APC LSR MACF1 ROCK1 MDGA1 NPAS4 | 1.19e-04 | 569 | 260 | 19 | GO:0034329 |
| GeneOntologyBiologicalProcess | regulation of anatomical structure size | MAP1B TRPC5 SH3BP1 DCC KIAA0319 PTK2B DRAXIN PLEKHH2 CX3CL1 COL6A1 FN1 PCLO CASR ALS2 SIRT1 PLXNA4 MACF1 ROCK1 ATP2B1 ATP2B2 | 1.20e-04 | 618 | 260 | 20 | GO:0090066 |
| GeneOntologyBiologicalProcess | cilium movement | ASH1L CFAP54 SLC22A14 CFAP45 CACNA1E CAMSAP3 CFAP43 DNAH1 CABS1 CFAP61 DNAAF1 ATP2B4 | 1.26e-04 | 261 | 260 | 12 | GO:0003341 |
| GeneOntologyBiologicalProcess | flagellated sperm motility | ASH1L CFAP54 SLC22A14 CFAP45 CACNA1E CFAP43 DNAH1 CABS1 CFAP61 ATP2B4 | 1.31e-04 | 186 | 260 | 10 | GO:0030317 |
| GeneOntologyBiologicalProcess | calcium ion transmembrane transport | TRPC5 PTK2B PKD1 PLCB3 CX3CL1 CACNA1E FLNA CACNB4 ANK2 SELENON PLCH1 ATP2B1 ATP2B2 ATP2B3 ATP2B4 | 1.46e-04 | 392 | 260 | 15 | GO:0070588 |
| GeneOntologyBiologicalProcess | membrane to membrane docking | 1.58e-04 | 2 | 260 | 2 | GO:0022614 | |
| GeneOntologyBiologicalProcess | cellular response to diamide | 1.58e-04 | 2 | 260 | 2 | GO:0072738 | |
| GeneOntologyBiologicalProcess | response to diamide | 1.58e-04 | 2 | 260 | 2 | GO:0072737 | |
| GeneOntologyBiologicalProcess | regulation of extent of cell growth | 1.60e-04 | 122 | 260 | 8 | GO:0061387 | |
| GeneOntologyBiologicalProcess | sperm motility | ASH1L CFAP54 SLC22A14 CFAP45 CACNA1E CFAP43 DNAH1 CABS1 CFAP61 ATP2B4 | 1.77e-04 | 193 | 260 | 10 | GO:0097722 |
| GeneOntologyBiologicalProcess | intracellular calcium ion homeostasis | TRPC5 PTK2B PLCB3 CX3CL1 FLNA CACNB4 ANK2 CASR SELENON PLCH1 ATP2B1 ATP2B2 ATP2B3 ATP2B4 | 2.00e-04 | 359 | 260 | 14 | GO:0006874 |
| GeneOntologyBiologicalProcess | protein localization to cell-cell junction | 2.15e-04 | 24 | 260 | 4 | GO:0150105 | |
| GeneOntologyBiologicalProcess | blood circulation | F5 KCNH2 SCNN1A TJP2 SERPING1 PKP2 PLCB3 CX3CL1 CACNA1E FLNA ANK2 ARHGEF12 CASR SIRT1 NISCH ROCK1 ATP2B1 ATP2B2 ATP2B3 ATP2B4 | 2.24e-04 | 648 | 260 | 20 | GO:0008015 |
| GeneOntologyBiologicalProcess | cell-cell adhesion | MAGI1 IGSF5 DCC DSCAML1 NEO1 FAT2 PKD1 TJP2 PKP2 SPARCL1 MAD2L2 PCDH10 CX3CL1 FLNA FAT4 SDK2 PCDHGB2 PCDHGA10 CAMSAP3 PCDHB4 PCDHA5 UFL1 PCDHA3 DCHS1 ASTN1 ROCK1 CARD11 MDGA1 | 2.37e-04 | 1077 | 260 | 28 | GO:0098609 |
| GeneOntologyBiologicalProcess | calcium ion transport | TRPC5 PTK2B PKD1 PLCB3 CX3CL1 CACNA1E FLNA CACNB4 LILRA2 ANK2 CASR SELENON PLCH1 ATP2B1 ATP2B2 ATP2B3 ATP2B4 | 2.70e-04 | 509 | 260 | 17 | GO:0006816 |
| GeneOntologyBiologicalProcess | cellular homeostasis | NCOA6 MAP1A TRPC5 PTK2B NEO1 NFE2L1 SCNN1A SCO1 PLCB3 CX3CL1 CACNA1E FLNA CACNB4 ANK2 APC CASR SELENON SLC40A1 SIRT1 RAB11FIP5 PLCH1 ATP2B1 ATP2B2 ATP2B3 ATP2B4 HCFC1 | 2.97e-04 | 981 | 260 | 26 | GO:0019725 |
| GeneOntologyBiologicalProcess | axonogenesis | MAP1A MAP1B TRPC5 DCC DSCAML1 KIAA0319 NEO1 DRAXIN PLXNB1 NOTCH3 HSPG2 FN1 APC LMTK2 ALS2 PLXNA4 MACF1 USP33 | 3.24e-04 | 566 | 260 | 18 | GO:0007409 |
| GeneOntologyBiologicalProcess | cilium movement involved in cell motility | ASH1L CFAP54 SLC22A14 CFAP45 CACNA1E CFAP43 DNAH1 CABS1 CFAP61 ATP2B4 | 3.48e-04 | 210 | 260 | 10 | GO:0060294 |
| GeneOntologyBiologicalProcess | regulation of axon extension | 3.50e-04 | 104 | 260 | 7 | GO:0030516 | |
| GeneOntologyBiologicalProcess | regulation of cellular component size | MAP1B TRPC5 SH3BP1 DCC KIAA0319 PTK2B DRAXIN PLEKHH2 COL6A1 FN1 PCLO ALS2 PLXNA4 MACF1 ATP2B2 | 3.56e-04 | 426 | 260 | 15 | GO:0032535 |
| GeneOntologyBiologicalProcess | inorganic ion homeostasis | TRPC5 PTK2B NEO1 KCNH2 SCNN1A SCO1 PLCB3 CX3CL1 FLNA CACNB4 ANK2 CASR SELENON SLC40A1 PLCH1 ATP2B1 ATP2B2 ATP2B3 ATP2B4 | 3.66e-04 | 622 | 260 | 19 | GO:0098771 |
| GeneOntologyBiologicalProcess | regulation of microtubule cytoskeleton organization | 4.08e-04 | 176 | 260 | 9 | GO:0070507 | |
| GeneOntologyBiologicalProcess | cilium-dependent cell motility | ASH1L CFAP54 SLC22A14 CFAP45 CACNA1E CFAP43 DNAH1 CABS1 CFAP61 ATP2B4 | 4.19e-04 | 215 | 260 | 10 | GO:0060285 |
| GeneOntologyBiologicalProcess | cilium or flagellum-dependent cell motility | ASH1L CFAP54 SLC22A14 CFAP45 CACNA1E CFAP43 DNAH1 CABS1 CFAP61 ATP2B4 | 4.19e-04 | 215 | 260 | 10 | GO:0001539 |
| GeneOntologyBiologicalProcess | establishment of cell polarity | 4.25e-04 | 177 | 260 | 9 | GO:0030010 | |
| GeneOntologyBiologicalProcess | establishment or maintenance of cell polarity | MAP1B SH3BP1 FRMD4B PKD1 CAMSAP3 APC PLEKHG3 MACF1 ROCK1 ANKFN1 ALPK2 | 4.42e-04 | 257 | 260 | 11 | GO:0007163 |
| GeneOntologyBiologicalProcess | calcium ion homeostasis | TRPC5 PTK2B PLCB3 CX3CL1 FLNA CACNB4 ANK2 CASR SELENON PLCH1 ATP2B1 ATP2B2 ATP2B3 ATP2B4 | 4.49e-04 | 389 | 260 | 14 | GO:0055074 |
| GeneOntologyBiologicalProcess | regulation of kinetochore assembly | 4.71e-04 | 3 | 260 | 2 | GO:0090234 | |
| GeneOntologyBiologicalProcess | maintenance of location in cell | PGR PTK2B PKP2 PLCB3 CX3CL1 FLNA ANK2 SELENON SIRT1 PLCH1 TOPORS | 4.71e-04 | 259 | 260 | 11 | GO:0051651 |
| GeneOntologyBiologicalProcess | negative regulation of protein tyrosine kinase activity | 5.22e-04 | 30 | 260 | 4 | GO:0061099 | |
| GeneOntologyBiologicalProcess | axon development | MAP1A MAP1B TRPC5 DCC DSCAML1 KIAA0319 NEO1 DRAXIN PLXNB1 NOTCH3 HSPG2 FLNA FN1 APC LMTK2 ALS2 PLXNA4 MACF1 USP33 | 5.38e-04 | 642 | 260 | 19 | GO:0061564 |
| GeneOntologyCellularComponent | apical junction complex | MAGI1 ASH1L SH3BP1 IGSF5 MPDZ FRMD4B TJP2 EPB41L4B CAMSAP3 APC LSR | 5.15e-06 | 158 | 262 | 11 | GO:0043296 |
| GeneOntologyCellularComponent | bicellular tight junction | 6.15e-06 | 131 | 262 | 10 | GO:0005923 | |
| GeneOntologyCellularComponent | tight junction | 1.04e-05 | 139 | 262 | 10 | GO:0070160 | |
| GeneOntologyCellularComponent | interphotoreceptor matrix | 3.79e-05 | 6 | 262 | 3 | GO:0033165 | |
| GeneOntologyCellularComponent | cell leading edge | SH3BP1 FRMD4B C2CD5 PTK2B PLEKHH2 USH2A DAGLA ITSN1 APC ALS2 TMEM87A ARAP3 MACF1 ROCK1 PLEKHO1 ATP2B1 ATP2B2 SNX2 | 6.54e-05 | 500 | 262 | 18 | GO:0031252 |
| GeneOntologyCellularComponent | distal axon | MAP1A MAP1B TRPC5 DCC PGR PTK2B NEO1 USH2A FLNA PCLO ITSN1 APC LMTK2 CASR ALS2 SIRT1 | 1.30e-04 | 435 | 262 | 16 | GO:0150034 |
| GeneOntologyCellularComponent | sperm principal piece | 2.17e-04 | 44 | 262 | 5 | GO:0097228 | |
| GeneOntologyCellularComponent | growth cone | 2.81e-04 | 245 | 262 | 11 | GO:0030426 | |
| GeneOntologyCellularComponent | site of polarized growth | 3.69e-04 | 253 | 262 | 11 | GO:0030427 | |
| GeneOntologyCellularComponent | postsynapse | GPR50 MAP1A MAP1B MPDZ DCC GPR179 PGR PTK2B NEO1 PLCB3 PCDH10 DAGLA CACNA1E FLNA SUSD4 ANK2 PCLO ITSN1 APC ALS2 SENP6 MACF1 SMCR8 ATP2B1 ATP2B2 NPAS4 | 4.79e-04 | 1018 | 262 | 26 | GO:0098794 |
| GeneOntologyCellularComponent | apical dendrite | 6.58e-04 | 32 | 262 | 4 | GO:0097440 | |
| GeneOntologyCellularComponent | neuronal cell body | MAP1A MAP1B TRPC5 PGR PTK2B NEO1 TTBK1 USH2A CX3CL1 CACNA1E FLNA PCLO ITSN1 APC LMTK2 CASR ALS2 ASTN1 ATP2B1 ATP2B2 HCFC1 USP33 | 8.77e-04 | 835 | 262 | 22 | GO:0043025 |
| GeneOntologyCellularComponent | cilium | MAP1A MAP1B FSCB CEP170 CFAP54 SLC22A14 CFAP45 PKD1 SCNN1A LRRC56 USH2A IQCE CAMSAP3 CFAP43 DNAH1 VCAN CABS1 CFAP61 DNAAF1 TOPORS ATP2B2 ATP2B4 PTTG2 | 9.80e-04 | 898 | 262 | 23 | GO:0005929 |
| GeneOntologyCellularComponent | ruffle | 1.21e-03 | 206 | 262 | 9 | GO:0001726 | |
| GeneOntologyCellularComponent | dendritic spine membrane | 1.38e-03 | 18 | 262 | 3 | GO:0032591 | |
| GeneOntologyCellularComponent | cell body | MAP1A MAP1B TRPC5 DAXX PGR PTK2B NEO1 TTBK1 USH2A CX3CL1 CACNA1E FLNA PCLO ITSN1 APC LMTK2 CASR ALS2 ASTN1 ATP2B1 ATP2B2 HCFC1 USP33 | 1.53e-03 | 929 | 262 | 23 | GO:0044297 |
| GeneOntologyCellularComponent | heterochromatin | 1.72e-03 | 101 | 262 | 6 | GO:0000792 | |
| HumanPheno | Periventricular nodular heterotopia | 8.80e-06 | 18 | 86 | 5 | HP:0032388 | |
| Domain | ATP_Ca_trans_C | 3.84e-08 | 4 | 263 | 4 | IPR022141 | |
| Domain | ATP_Ca_trans_C | 3.84e-08 | 4 | 263 | 4 | PF12424 | |
| Domain | LRRC37AB_C | 3.84e-08 | 4 | 263 | 4 | IPR029423 | |
| Domain | FAM72 | 3.84e-08 | 4 | 263 | 4 | IPR026768 | |
| Domain | LRRC37AB_C | 3.84e-08 | 4 | 263 | 4 | PF14914 | |
| Domain | FAM72 | 3.84e-08 | 4 | 263 | 4 | PF14976 | |
| Domain | LRRC37_N | 3.84e-08 | 4 | 263 | 4 | IPR032754 | |
| Domain | LRRC37 | 3.84e-08 | 4 | 263 | 4 | PF15779 | |
| Domain | P-type_ATPase_IIB | 3.84e-08 | 4 | 263 | 4 | IPR006408 | |
| Domain | LRRC37A/B-like | 3.84e-08 | 4 | 263 | 4 | IPR015753 | |
| Domain | FN3 | DCC CMYA5 DSCAML1 KIAA0319 NEO1 FNDC7 USH2A SDK2 COL12A1 FN1 ASTN1 LRRN4 MDGA1 ANKFN1 HCFC1 | 5.86e-08 | 185 | 263 | 15 | SM00060 |
| Domain | FN3_dom | DCC CMYA5 DSCAML1 KIAA0319 NEO1 FNDC7 USH2A SDK2 COL12A1 FN1 ASTN1 LRRN4 MDGA1 ANKFN1 HCFC1 | 2.90e-07 | 209 | 263 | 15 | IPR003961 |
| Domain | Cadherin | KIAA0319 FAT2 PCDH10 FAT4 PCDHGB2 PCDHGA10 PCDHB4 PCDHA5 PCDHA3 FREM3 DCHS1 | 8.87e-07 | 118 | 263 | 11 | IPR002126 |
| Domain | FN3 | DCC CMYA5 DSCAML1 NEO1 FNDC7 USH2A SDK2 COL12A1 FN1 ASTN1 LRRN4 MDGA1 ANKFN1 HCFC1 | 9.22e-07 | 199 | 263 | 14 | PS50853 |
| Domain | - | IGSF5 DCC CMYA5 DSCAML1 NEO1 FNDC7 KIR3DS1 USH2A PLXNB1 HSPG2 FLNA LILRA3 LILRA2 SDK2 COL12A1 FN1 TIMD4 LSR VCAN PLXNA4 ASTN1 LRRN4 MDGA1 ANKFN1 HCFC1 ALPK2 | 2.61e-06 | 663 | 263 | 26 | 2.60.40.10 |
| Domain | Ig-like_fold | IGSF5 DCC CMYA5 DSCAML1 KIAA0319 NEO1 FNDC7 KIR3DS1 USH2A PLXNB1 HSPG2 FLNA LILRA3 LILRA2 SDK2 COL12A1 FN1 TIMD4 LSR VCAN PLXNA4 ASTN1 LRRN4 MDGA1 ANKFN1 HCFC1 ALPK2 | 2.65e-06 | 706 | 263 | 27 | IPR013783 |
| Domain | SEA | 1.15e-05 | 22 | 263 | 5 | PF01390 | |
| Domain | SEA | 1.46e-05 | 23 | 263 | 5 | PS50024 | |
| Domain | SEA_dom | 1.46e-05 | 23 | 263 | 5 | IPR000082 | |
| Domain | fn3 | DCC CMYA5 DSCAML1 NEO1 FNDC7 USH2A SDK2 COL12A1 FN1 LRRN4 ANKFN1 | 1.92e-05 | 162 | 263 | 11 | PF00041 |
| Domain | Cadherin_CS | FAT2 PCDH10 FAT4 PCDHGB2 PCDHGA10 PCDHB4 PCDHA5 PCDHA3 DCHS1 | 2.37e-05 | 109 | 263 | 9 | IPR020894 |
| Domain | CADHERIN_1 | FAT2 PCDH10 FAT4 PCDHGB2 PCDHGA10 PCDHB4 PCDHA5 PCDHA3 DCHS1 | 3.17e-05 | 113 | 263 | 9 | PS00232 |
| Domain | Cadherin | FAT2 PCDH10 FAT4 PCDHGB2 PCDHGA10 PCDHB4 PCDHA5 PCDHA3 DCHS1 | 3.17e-05 | 113 | 263 | 9 | PF00028 |
| Domain | CADHERIN_2 | FAT2 PCDH10 FAT4 PCDHGB2 PCDHGA10 PCDHB4 PCDHA5 PCDHA3 DCHS1 | 3.40e-05 | 114 | 263 | 9 | PS50268 |
| Domain | - | FAT2 PCDH10 FAT4 PCDHGB2 PCDHGA10 PCDHB4 PCDHA5 PCDHA3 DCHS1 | 3.40e-05 | 114 | 263 | 9 | 2.60.40.60 |
| Domain | CA | FAT2 PCDH10 FAT4 PCDHGB2 PCDHGA10 PCDHB4 PCDHA5 PCDHA3 DCHS1 | 3.64e-05 | 115 | 263 | 9 | SM00112 |
| Domain | Cadherin-like | FAT2 PCDH10 FAT4 PCDHGB2 PCDHGA10 PCDHB4 PCDHA5 PCDHA3 DCHS1 | 3.90e-05 | 116 | 263 | 9 | IPR015919 |
| Domain | ATPase_P-typ_TM_dom | 6.12e-05 | 16 | 263 | 4 | IPR023298 | |
| Domain | - | 6.12e-05 | 16 | 263 | 4 | 1.20.1110.10 | |
| Domain | ATPase_P-typ_cation-transptr_C | 7.92e-05 | 17 | 263 | 4 | IPR006068 | |
| Domain | Cation_ATPase_C | 7.92e-05 | 17 | 263 | 4 | PF00689 | |
| Domain | Cation_ATPase_N | 1.01e-04 | 18 | 263 | 4 | PF00690 | |
| Domain | Cation_ATPase_N | 1.01e-04 | 18 | 263 | 4 | SM00831 | |
| Domain | ATPase_P-typ_cation-transptr_N | 1.26e-04 | 19 | 263 | 4 | IPR004014 | |
| Domain | Leu-rich_rpt | LRRC37A3 LRRC37A2 LRRC37A TONSL PKD1 LRRC56 NLRC5 CEP97 EPYC NISCH LRRN4 DNAAF1 LRRC37B | 1.30e-04 | 271 | 263 | 13 | IPR001611 |
| Domain | LRR | LRRC37A3 LRRC37A2 LRRC37A PKD1 LRRC56 NLRC5 CEP97 EPYC NISCH DNAAF1 LRRC37B | 1.36e-04 | 201 | 263 | 11 | PS51450 |
| Domain | - | LRRC37A3 LRRC37A2 LRRC37A TONSL PKD1 LRRC56 NLRC5 CEP97 EPYC CMIP NISCH LRRN4 DNAAF1 LRRC37B | 1.95e-04 | 321 | 263 | 14 | 3.80.10.10 |
| Domain | Neogenin_C | 1.98e-04 | 2 | 263 | 2 | IPR010560 | |
| Domain | Neogenin_C | 1.98e-04 | 2 | 263 | 2 | PF06583 | |
| Domain | ATP2B1/4 | 1.98e-04 | 2 | 263 | 2 | IPR030319 | |
| Domain | L_dom-like | LRRC37A3 LRRC37A2 LRRC37A TONSL PKD1 LRRC56 NLRC5 CEP97 EPYC CMIP NISCH LRRN4 DNAAF1 LRRC37B | 2.43e-04 | 328 | 263 | 14 | IPR032675 |
| Domain | Cadherin_2 | 3.03e-04 | 65 | 263 | 6 | PF08266 | |
| Domain | Cadherin_N | 3.03e-04 | 65 | 263 | 6 | IPR013164 | |
| Domain | PH_dom-like | FRMD4B PTK2B PLCB3 PLEKHH2 EPB41L4B ITSN1 ARHGEF12 ALS2 WDFY4 PPP4R3A CMIP ARAP3 PLEKHG3 ROCK1 PLCH1 PLEKHO1 | 3.76e-04 | 426 | 263 | 16 | IPR011993 |
| Domain | AT_hook | 5.23e-04 | 27 | 263 | 4 | SM00384 | |
| Domain | AT_hook_DNA-bd_motif | 5.23e-04 | 27 | 263 | 4 | IPR017956 | |
| Domain | MAP1 | 5.87e-04 | 3 | 263 | 2 | IPR026074 | |
| Domain | SEA | 8.96e-04 | 14 | 263 | 3 | SM00200 | |
| Domain | ANK_REPEAT | ANKRD31 TRPC5 ANKRD30B ANKAR TONSL ANKIB1 NOTCH3 ANK2 MUC16 ANKRD30A ANKFN1 | 9.58e-04 | 253 | 263 | 11 | PS50088 |
| Domain | ANK_REP_REGION | ANKRD31 TRPC5 ANKRD30B ANKAR TONSL ANKIB1 NOTCH3 ANK2 MUC16 ANKRD30A ANKFN1 | 9.89e-04 | 254 | 263 | 11 | PS50297 |
| Domain | LRR_1 | LRRC37A3 LRRC37A2 LRRC37A LRRC56 NLRC5 CEP97 NISCH LRRN4 DNAAF1 LRRC37B | 1.12e-03 | 219 | 263 | 10 | PF00560 |
| Domain | Laminin_G | 1.33e-03 | 58 | 263 | 5 | IPR001791 | |
| Domain | ATPase_P-typ_cyto_domN | 1.43e-03 | 35 | 263 | 4 | IPR023299 | |
| Domain | ATPase_P-typ_P_site | 1.59e-03 | 36 | 263 | 4 | IPR018303 | |
| Domain | P_typ_ATPase | 1.59e-03 | 36 | 263 | 4 | IPR001757 | |
| Domain | ATPASE_E1_E2 | 1.59e-03 | 36 | 263 | 4 | PS00154 | |
| Domain | Cadherin_tail | 1.76e-03 | 37 | 263 | 4 | PF15974 | |
| Domain | ATPase_P-typ_transduc_dom_A | 1.76e-03 | 37 | 263 | 4 | IPR008250 | |
| Domain | Cadherin_CBD | 1.76e-03 | 37 | 263 | 4 | IPR031904 | |
| Domain | E1-E2_ATPase | 1.76e-03 | 37 | 263 | 4 | PF00122 | |
| Domain | AWS | 1.92e-03 | 5 | 263 | 2 | SM00570 | |
| Domain | AWS | 1.92e-03 | 5 | 263 | 2 | PS51215 | |
| Domain | AWS_dom | 1.92e-03 | 5 | 263 | 2 | IPR006560 | |
| Domain | LAM_G_DOMAIN | 1.95e-03 | 38 | 263 | 4 | PS50025 | |
| Pathway | REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS | 1.12e-05 | 12 | 178 | 4 | M27326 | |
| Pathway | REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS | 2.23e-05 | 14 | 178 | 4 | MM15052 | |
| Pubmed | NCOA6 CAND2 CDK12 NACAD FRMD4B ANKIB1 PAN2 DOCK6 DAGLA SYT13 PLXNB1 IQCE ZNF687 SDK2 HECTD4 LMTK2 UFL1 PCDHA3 TRIM33 SETBP1 SENP6 SDC3 RAB11FIP5 DEPDC5 CNOT1 | 7.44e-13 | 529 | 269 | 25 | 14621295 | |
| Pubmed | TBC1D9B KDM4C GATAD2B TBC1D9 C2CD5 CEP170 PHF2 FAT2 TOX4 TTBK1 PLEKHH2 CSTF2T WDFY4 THOC5 PPP4R3A SETD2 CMIP PLEKHG3 MACF1 SPIDR PLCH1 | 3.64e-10 | 493 | 269 | 21 | 15368895 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | ZHX3 NCOA6 CDK12 DAXX GATAD2B TBC1D9 C2CD5 ZBTB40 TJP2 PLCB3 HSF1 CSTF2T ZNF687 FLNA ITSN1 RALGAPB CAMSAP3 UFL1 SIRT1 PPP4R3A SETD2 ABCB9 SENP6 TOPORS SRRM2 SNX2 | 4.67e-10 | 774 | 269 | 26 | 15302935 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ALKBH4 NCOA6 TBC1D9B PPRC1 CDK12 TBC1D9 FOCAD KCNH2 PKD1 ZNF398 LRRC56 NLRC5 DOCK6 MYRF IQCE ZNF687 HSPG2 FLNA HECTD4 LMTK2 ZDHHC7 CFAP43 ARAP3 GAREM2 NISCH ZNF408 DEPDC5 DOT1L GGA1 HCFC1 | 3.04e-09 | 1105 | 269 | 30 | 35748872 |
| Pubmed | Cell-specific expression of plasma membrane calcium ATPase isoforms in retinal neurons. | 3.50e-09 | 4 | 269 | 4 | 12209837 | |
| Pubmed | 3.50e-09 | 4 | 269 | 4 | 23413890 | ||
| Pubmed | Quantitative analysis of alternative splicing options of human plasma membrane calcium pump genes. | 3.50e-09 | 4 | 269 | 4 | 8245032 | |
| Pubmed | Quantitative analysis of alternative splicing options of human plasma membrane calcium pump genes. | 3.50e-09 | 4 | 269 | 4 | 7989379 | |
| Pubmed | PMCA1 depletion in mouse eggs amplifies calcium signaling and impacts offspring growth†. | 3.50e-09 | 4 | 269 | 4 | 36130203 | |
| Pubmed | 3.50e-09 | 4 | 269 | 4 | 10577388 | ||
| Pubmed | Structural organization, ion transport, and energy transduction of P-type ATPases. | 3.50e-09 | 4 | 269 | 4 | 8634322 | |
| Pubmed | Fam72a enforces error-prone DNA repair during antibody diversification. | 3.50e-09 | 4 | 269 | 4 | 34819671 | |
| Pubmed | 3.50e-09 | 4 | 269 | 4 | 12784250 | ||
| Pubmed | Role of alternative splicing in generating isoform diversity among plasma membrane calcium pumps. | 3.50e-09 | 4 | 269 | 4 | 11152753 | |
| Pubmed | Developmental expression of the four plasma membrane calcium ATPase (Pmca) genes in the mouse. | 3.50e-09 | 4 | 269 | 4 | 10434059 | |
| Pubmed | 3.50e-09 | 4 | 269 | 4 | 15101689 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | MAGI1 POU6F2 MAP1B ASH1L COG3 CEP170 PHF2 ANKAR VPS35L SCNN1A ANKIB1 NLRC5 TRMT13 HOOK2 DOCK6 DAGLA NOTCH3 EPB41L4B RALGAPB HECTD4 CAMSAP3 SELENON HPS3 DNAH1 CMIP RNF4 PLEKHG3 SETBP1 SDC3 MACF1 SPIDR EIF4G3 ATP2B1 CNOT1 SNX2 | 5.56e-09 | 1489 | 269 | 35 | 28611215 |
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 1.57e-08 | 38 | 269 | 7 | 30786075 | |
| Pubmed | MAP1A MAP1B C2CD5 PRRT3 CACNA1E CACNB4 ANK2 PCLO ITSN1 CAMSAP3 APC RAB11FIP5 MACF1 EIF4G3 SRRM2 ATP2B2 | 1.60e-08 | 347 | 269 | 16 | 17114649 | |
| Pubmed | Identification and characterisation of the novel amyloid-beta peptide-induced protein p17. | 1.74e-08 | 5 | 269 | 4 | 19755123 | |
| Pubmed | 1.74e-08 | 5 | 269 | 4 | 26206078 | ||
| Pubmed | 1.74e-08 | 5 | 269 | 4 | 17938178 | ||
| Pubmed | Cardiac excitation-contraction coupling in the absence of Na(+) - Ca2+ exchange. | 5.19e-08 | 6 | 269 | 4 | 12767889 | |
| Pubmed | FAM72A antagonizes UNG2 to promote mutagenic repair during antibody maturation. | 5.19e-08 | 6 | 269 | 4 | 34819670 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | MAGI1 NCOA6 MAP1B MPDZ CEP170 PTK2B TJP2 PKP2 DOCK6 RALGAPB CAMSAP3 APC LMTK2 ALS2 MAP3K6 LSR PLEKHG3 RAB11FIP5 MACF1 PLCH1 EIF4G3 SRRM2 ATP2B1 SNX2 | 7.76e-08 | 861 | 269 | 24 | 36931259 |
| Pubmed | CAND2 PPRC1 ASH1L NT5DC1 C2CD5 NFE2L1 VPS35L ZBTB40 PAN2 TJP2 PLXNB1 FLNA FN1 EPB41L4B ITSN1 AKNAD1 APC LMTK2 ALS2 SALL4 WDFY4 VCAN MACF1 ROCK1 DOT1L ATP2B1 CNOT1 | 1.13e-07 | 1084 | 269 | 27 | 11544199 | |
| Pubmed | NCOA6 CDK12 MYOD1 ASH1L GATAD2B TOX4 PKD1 PKP2 SPARCL1 HSPG2 FLNA FN1 ITSN1 BTBD2 RNF4 MACF1 ROCK1 TOPORS GGA1 | 2.19e-07 | 591 | 269 | 19 | 15231748 | |
| Pubmed | 2.39e-07 | 8 | 269 | 4 | 10951186 | ||
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | MAP1A MAP1B PTK2B PRRT3 TJP2 DAGLA CACNA1E CACNB4 PCLO ITSN1 MACF1 SRRM2 | 2.89e-07 | 231 | 269 | 12 | 16452087 |
| Pubmed | 4.58e-07 | 3 | 269 | 3 | 19491102 | ||
| Pubmed | 6.06e-07 | 125 | 269 | 9 | 29467281 | ||
| Pubmed | 7.09e-07 | 10 | 269 | 4 | 23064749 | ||
| Pubmed | MAP1B CDK12 MPDZ NOP9 TONSL ANKIB1 PLCB3 HOOK2 PLXNB1 EPB41L4B RALGAPB CAMSAP3 APC MAP3K6 ARAP3 NISCH PLCH1 HCFC1 USP33 | 9.15e-07 | 650 | 269 | 19 | 38777146 | |
| Pubmed | 1.35e-06 | 102 | 269 | 8 | 9734811 | ||
| Pubmed | A striking organization of a large family of human neural cadherin-like cell adhesion genes. | 1.47e-06 | 72 | 269 | 7 | 10380929 | |
| Pubmed | ZHX3 NCOA6 CDK12 DSCAML1 PHF2 ZBTB40 DAGLA RALGAPB ALS2 SETBP1 MACF1 | 1.64e-06 | 225 | 269 | 11 | 12168954 | |
| Pubmed | 1.82e-06 | 4 | 269 | 3 | 22419166 | ||
| Pubmed | FAM114A1 CAND2 CMYA5 CEP170 NEO1 BNIP2 NFE2L1 ZBTB40 HOOK2 MAD2L2 NOTCH3 HSPG2 COL12A1 FN1 ANK2 MACF1 | 1.99e-06 | 497 | 269 | 16 | 23414517 | |
| Pubmed | 2.32e-06 | 77 | 269 | 7 | 10835267 | ||
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | NR2C2 MAP1A MAP1B GPN1 DAXX GATAD2B CEP170 HSF1 CEP97 FLNA TRIM33 SENP6 MTRR RAB11FIP5 HCFC1 | 2.32e-06 | 444 | 269 | 15 | 34795231 |
| Pubmed | MAP1A MAP1B CEP170 PTK2B TJP2 DAGLA FLNA CACNB4 FN1 ANK2 EPB41L4B PCLO ITSN1 RBP3 CAMSAP3 APC ARHGEF12 NISCH VCAN PLXNA4 MACF1 PLCH1 EIF4G3 ATP2B1 ATP2B2 CNOT1 ATP2B3 ATP2B4 SNX2 | 2.52e-06 | 1431 | 269 | 29 | 37142655 | |
| Pubmed | FAM114A1 MAP1B PPRC1 ASH1L GATB ANKRD30B DCC CLCN5 SLC22A14 CFAP45 METTL25 CACNA1E FLNA ANK2 PCDHGB2 PCDHGA10 PCLO ITSN1 CAMSAP3 ABCB9 PLXNA4 ANKRD30A MACF1 PLCH1 EIF4G3 USPL1 ATP2B1 ATP2B2 ATP2B3 | 2.92e-06 | 1442 | 269 | 29 | 35575683 | |
| Pubmed | Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes. | 3.01e-06 | 80 | 269 | 7 | 10716726 | |
| Pubmed | 4.47e-06 | 15 | 269 | 4 | 1741163 | ||
| Pubmed | ZNF131 NR2C2 CAND2 ATAD5 GATB MPDZ SSR1 C2CD5 NEO1 TXNDC5 SCO1 ANK2 ITSN1 RALGAPB UFL1 THOC5 SIRT1 LSR NISCH RAB11FIP5 MACF1 PLCH1 EIF4G3 SRRM2 SMCR8 ATP2B1 ATP2B4 SNX2 USP33 | 5.27e-06 | 1487 | 269 | 29 | 33957083 | |
| Pubmed | ZNF131 ZHX3 PHF20 KDM4C MYOD1 ASH1L GATAD2B PHF2 ZBTB37 TOX4 NFE2L1 ZNF398 HSF1 ZNF282 ZNF687 ZDHHC7 SALL4 LSR WBP4 ZNF654 | 5.82e-06 | 808 | 269 | 20 | 20412781 | |
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | NCKAP5 DCC FRMD4B CASTOR1 HSPG2 FLNA COL12A1 FN1 EPB41L4B HECTD4 ALS2 ATP2B1 USP33 | 5.92e-06 | 363 | 269 | 13 | 14691545 |
| Pubmed | 5.92e-06 | 16 | 269 | 4 | 12787792 | ||
| Pubmed | KDM4C PPRC1 ASH1L NCKAP5 CMYA5 DSCAML1 FRMD4B FOCAD VPS35L PKD1 SPARCL1 FN1 ANK2 ITSN1 HECTD4 APC BTBD2 TRIM33 NISCH SENP6 MACF1 ASTN1 EIF4G3 USPL1 ECE2 USP33 | 8.81e-06 | 1285 | 269 | 26 | 35914814 | |
| Pubmed | 9.00e-06 | 6 | 269 | 3 | 12763866 | ||
| Pubmed | 9.00e-06 | 6 | 269 | 3 | 12122449 | ||
| Pubmed | 9.00e-06 | 6 | 269 | 3 | 19506035 | ||
| Pubmed | 9.00e-06 | 6 | 269 | 3 | 18384059 | ||
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 1.10e-05 | 135 | 269 | 8 | 28675934 | |
| Pubmed | ZHX3 NCOA6 LRRC37A3 ATAD5 IGSF5 SSR1 TXNDC5 ZNF687 FAT4 MUC16 WBP4 RAB11FIP5 DNAAF1 SMCR8 ATP2B1 CNOT1 ATP2B3 | 1.16e-05 | 638 | 269 | 17 | 31182584 | |
| Pubmed | 1.36e-05 | 67 | 269 | 6 | 29254152 | ||
| Pubmed | Comparative DNA sequence analysis of mouse and human protocadherin gene clusters. | 1.48e-05 | 68 | 269 | 6 | 11230163 | |
| Pubmed | 1.54e-05 | 20 | 269 | 4 | 29084951 | ||
| Pubmed | 1.57e-05 | 7 | 269 | 3 | 16059920 | ||
| Pubmed | 1.57e-05 | 7 | 269 | 3 | 12242711 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | MAP1A DAXX TONSL MAD2L2 ITSN1 APC SIRT1 PPP4R3A TRIM33 SETD2 SENP6 RAB11FIP5 MACF1 ROCK1 DOT1L TOPORS | 1.63e-05 | 588 | 269 | 16 | 38580884 |
| Pubmed | 1.83e-05 | 105 | 269 | 7 | 9628581 | ||
| Pubmed | CDK12 MPDZ FRMD4B GATAD2B CEP170 NEO1 TJP2 PRR14L ZNF687 ITSN1 APC ZDHHC7 SETD2 WBP4 ROCK1 PLCH1 HCFC1 USP33 | 1.91e-05 | 733 | 269 | 18 | 34672954 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | DSCAML1 FOCAD PKD1 PLCB3 PCDH10 FBXO34 IQCE FAT4 FN1 EPB41L4B COL28A1 PCLO ITSN1 CAMSAP3 PCDHA5 ZNF408 PLXNA4 CNOT1 | 2.01e-05 | 736 | 269 | 18 | 29676528 |
| Pubmed | Cadherin superfamily genes: functions, genomic organization, and neurologic diversity. | 2.41e-05 | 74 | 269 | 6 | 10817752 | |
| Pubmed | 2.71e-05 | 153 | 269 | 8 | 25037231 | ||
| Pubmed | 2.71e-05 | 153 | 269 | 8 | 10718198 | ||
| Pubmed | GPR50 MAP1A DBNDD2 GATB CEP170 VPS35L CX3CL1 SYT13 CACNA1E FLNA CACNB4 LILRA2 COL12A1 APC ALS2 UFL1 SPATA32 PPP1R1A VCAN ANKRD30A DEPDC5 LRRN4 SMCR8 GGA1 PLEKHO1 | 2.80e-05 | 1293 | 269 | 25 | 15342556 | |
| Pubmed | 3.29e-05 | 24 | 269 | 4 | 24698270 | ||
| Pubmed | 3.71e-05 | 9 | 269 | 3 | 28705793 | ||
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | MAGI1 TJP2 PKP2 PLCB3 NOTCH3 FLNA EPB41L4B ARHGEF12 TMEM87A LSR MACF1 ATP2B1 ATP2B4 HCFC1 SNX2 | 3.97e-05 | 565 | 269 | 15 | 25468996 |
| Pubmed | 4.25e-05 | 50 | 269 | 5 | 23658023 | ||
| Pubmed | MAGI1 MAP1B MPDZ CEP170 PKP2 ANK2 APC ARHGEF12 RAB11FIP5 MACF1 ROCK1 PLCH1 EIF4G3 SMCR8 ATP2B1 CNOT1 HCFC1 | 4.30e-05 | 708 | 269 | 17 | 39231216 | |
| Pubmed | 5.06e-05 | 167 | 269 | 8 | 22159717 | ||
| Pubmed | 5.27e-05 | 10 | 269 | 3 | 19071123 | ||
| Pubmed | ZNF131 ZHX3 NCOA6 NR2C2 JDP2 GATAD2B CEP170 PHF2 TXNDC5 ZBTB40 CSTF2T ZNF687 FLNA ZBTB9 PPAT SIRT1 PPP4R3A TRIM33 SMS SRRM2 CNOT1 HCFC1 | 5.47e-05 | 1103 | 269 | 22 | 34189442 | |
| Pubmed | Proteomic analysis of in vivo phosphorylated synaptic proteins. | 5.65e-05 | 53 | 269 | 5 | 15572359 | |
| Pubmed | A mouse model for endometrioid ovarian cancer arising from the distal oviduct. | 5.96e-05 | 2 | 269 | 2 | 24474556 | |
| Pubmed | DCC constrains tumour progression via its dependence receptor activity. | 5.96e-05 | 2 | 269 | 2 | 22158121 | |
| Pubmed | 5.96e-05 | 2 | 269 | 2 | 18657858 | ||
| Pubmed | Regulation of microtubule-associated protein 1B (MAP1B) subunit composition. | 5.96e-05 | 2 | 269 | 2 | 11002287 | |
| Pubmed | JAM4, a junctional cell adhesion molecule interacting with a tight junction protein, MAGI-1. | 5.96e-05 | 2 | 269 | 2 | 12773569 | |
| Pubmed | 5.96e-05 | 2 | 269 | 2 | 25822366 | ||
| Pubmed | Versican provides the provisional matrix for uterine spiral artery dilation and fetal growth. | 5.96e-05 | 2 | 269 | 2 | 36423736 | |
| Pubmed | 5.96e-05 | 2 | 269 | 2 | 28576827 | ||
| Pubmed | 5.96e-05 | 2 | 269 | 2 | 34149611 | ||
| Pubmed | 5.96e-05 | 2 | 269 | 2 | 35906886 | ||
| Pubmed | 5.96e-05 | 2 | 269 | 2 | 15128042 | ||
| Pubmed | SIRT1 deficiency attenuates MPP+-induced apoptosis in dopaminergic cells. | 5.96e-05 | 2 | 269 | 2 | 21130087 | |
| Pubmed | A heart segmental defect in the anterior-posterior axis of a transgenic mutant mouse. | 5.96e-05 | 2 | 269 | 2 | 9188753 | |
| Pubmed | Kinetic characterization of human histone H3 lysine 36 methyltransferases, ASH1L and SETD2. | 5.96e-05 | 2 | 269 | 2 | 26002201 | |
| Pubmed | 5.96e-05 | 2 | 269 | 2 | 22252018 | ||
| Pubmed | 5.96e-05 | 2 | 269 | 2 | 28327142 | ||
| Pubmed | 5.96e-05 | 2 | 269 | 2 | 31331361 | ||
| Pubmed | 5.96e-05 | 2 | 269 | 2 | 25775433 | ||
| Pubmed | 5.96e-05 | 2 | 269 | 2 | 25690014 | ||
| Pubmed | Regulation of plasma membrane Ca2+-ATPase by small GTPases and phosphoinositides in human platelets. | 5.96e-05 | 2 | 269 | 2 | 10748016 | |
| Pubmed | The mouse and rat MAP1B genes: genomic organization and alternative transcription. | 5.96e-05 | 2 | 269 | 2 | 9615228 | |
| Pubmed | 5.96e-05 | 2 | 269 | 2 | 16236820 | ||
| Pubmed | 5.96e-05 | 2 | 269 | 2 | 25925258 | ||
| Interaction | OCLN interactions | MAGI1 PDE8A TJP2 PKP2 PCDH10 SDK2 ANK2 EPB41L4B ITSN1 APC LMTK2 ARHGEF12 TMEM87A SIRT1 LSR RNF4 NISCH RAB11FIP5 MACF1 PLCH1 ATP2B1 ATP2B4 | 7.52e-07 | 500 | 263 | 22 | int:OCLN |
| Interaction | FLOT1 interactions | MAGI1 PDE8A MPDZ PKP2 FLNA FN1 ANK2 PCLO ITSN1 APC LMTK2 ARHGEF12 LSR RNF4 NISCH RAB11FIP5 MACF1 ROCK1 DOT1L PLCH1 ATP2B1 | 1.25e-06 | 475 | 263 | 21 | int:FLOT1 |
| Interaction | PCDHGB1 interactions | 7.31e-06 | 77 | 263 | 8 | int:PCDHGB1 | |
| Interaction | LYN interactions | NR2C2 PDE8A C2CD5 PHF2 PTK2B PAN2 PKP2 PLEKHH2 CEP97 SDK2 ANK2 EPB41L4B ITSN1 APC LMTK2 LSR CBX6 NISCH RAB11FIP5 MACF1 ROCK1 PLCH1 SRRM2 ATP2B1 ATP2B4 | 9.15e-06 | 720 | 263 | 25 | int:LYN |
| Interaction | C17orf78 interactions | 1.29e-05 | 12 | 263 | 4 | int:C17orf78 | |
| Interaction | C2CD4B interactions | 2.17e-05 | 44 | 263 | 6 | int:C2CD4B | |
| Interaction | HSD17B6 interactions | 3.46e-05 | 15 | 263 | 4 | int:HSD17B6 | |
| Cytoband | 5q31 | 6.31e-05 | 115 | 269 | 6 | 5q31 | |
| GeneFamily | Fibronectin type III domain containing | DCC CMYA5 DSCAML1 NEO1 FNDC7 USH2A SDK2 COL12A1 FN1 ASTN1 LRRN4 ANKFN1 | 7.48e-08 | 160 | 181 | 12 | 555 |
| GeneFamily | ATPases Ca2+ transporting | 1.18e-06 | 9 | 181 | 4 | 1209 | |
| GeneFamily | Calcium voltage-gated channel subunits|Membrane associated guanylate kinases | 1.22e-04 | 26 | 181 | 4 | 904 | |
| GeneFamily | Ankyrin repeat domain containing | ANKRD31 ANKRD30B ANKAR TONSL ANKIB1 NOTCH3 ANK2 ARAP3 ANKRD30A ANKFN1 | 1.68e-04 | 242 | 181 | 10 | 403 |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 2.21e-04 | 161 | 181 | 8 | 593 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 4.46e-04 | 36 | 181 | 4 | 823 | |
| GeneFamily | Clustered protocadherins | 4.50e-04 | 64 | 181 | 5 | 20 | |
| GeneFamily | Cadherin related | 6.05e-04 | 17 | 181 | 3 | 24 | |
| GeneFamily | Immunoglobulin like domain containing | 7.40e-04 | 193 | 181 | 8 | 594 | |
| GeneFamily | Collagens | 1.14e-03 | 46 | 181 | 4 | 490 | |
| GeneFamily | CD molecules|Activating leukocyte immunoglobulin like receptors | 1.46e-03 | 6 | 181 | 2 | 1181 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 1.56e-03 | 50 | 181 | 4 | 1293 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 2.34e-03 | 181 | 181 | 7 | 694 | |
| GeneFamily | Plexins | 3.43e-03 | 9 | 181 | 2 | 683 | |
| GeneFamily | PDZ domain containing | 4.31e-03 | 152 | 181 | 6 | 1220 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 4.32e-03 | 66 | 181 | 4 | 722 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 4.70e-03 | 34 | 181 | 3 | 487 | |
| GeneFamily | EF-hand domain containing | 6.62e-03 | 219 | 181 | 7 | 863 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | PLEKHH2 COL6A1 SDK2 FN1 ANK2 COL6A6 SLC40A1 VCAN PDGFD PLXNA4 SDC3 MACF1 | 3.20e-09 | 199 | 267 | 12 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | SPARCL1 PLEKHH2 COL6A1 SDK2 FN1 ANK2 COL6A6 SLC40A1 VCAN PDGFD SDC3 MACF1 | 3.20e-09 | 199 | 267 | 12 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | SERPING1 PLEKHH2 COL6A1 SDK2 ANK2 COL6A6 ITSN1 SLC40A1 VCAN PDGFD SDC3 MACF1 | 3.20e-09 | 199 | 267 | 12 | e1849505b92820a219c5a2c35492bdd55579fb48 |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | SERPING1 SPARCL1 PLEKHH2 COL6A1 FN1 ANK2 COL6A6 VCAN PDGFD PLXNA4 SDC3 MACF1 | 3.39e-09 | 200 | 267 | 12 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | SERPING1 SPARCL1 PLEKHH2 COL6A1 SDK2 ANK2 COL6A6 ITSN1 SLC40A1 PDGFD SDC3 MACF1 | 3.39e-09 | 200 | 267 | 12 | b79628fd1386aa9a3b0e9fa81def0bc100c3c073 |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | SERPING1 SPARCL1 PLEKHH2 COL6A1 SDK2 ANK2 COL6A6 ITSN1 SLC40A1 PDGFD SDC3 MACF1 | 3.39e-09 | 200 | 267 | 12 | 50ca6550998e461ef26dd670351060bd940765a8 |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | SERPING1 PLEKHH2 COL6A1 SDK2 ANK2 COL6A6 ITSN1 VCAN PDGFD PLXNA4 SDC3 MACF1 | 3.39e-09 | 200 | 267 | 12 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | ASH1L MPDZ NCKAP5 FAM13B SPARCL1 DOCK6 FAT4 COL12A1 ARHGEF12 ARAP3 MACF1 PLEKHO1 | 3.39e-09 | 200 | 267 | 12 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | SPARCL1 PLEKHH2 COL6A1 SDK2 FN1 ANK2 COL6A6 SLC40A1 VCAN PDGFD SDC3 MACF1 | 3.39e-09 | 200 | 267 | 12 | 44a68bacdb3d5bf563bd35952176995850933a81 |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | SPARCL1 PLEKHH2 COL6A1 SDK2 FN1 ANK2 COL6A6 SLC40A1 VCAN PDGFD SDC3 MACF1 | 3.39e-09 | 200 | 267 | 12 | dc61016c61729f69649cfb21f6264e685ce83dea |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | PGR SERPING1 SPARCL1 PLEKHH2 COL6A1 FAT4 FN1 ANK2 COL6A6 SETBP1 MACF1 | 3.23e-08 | 197 | 267 | 11 | 94a9603cbd3516fbcce871909693b88f20d41713 |
| ToppCell | LPS_only-Epithelial_airway-airway_epithelial-Ciliated|LPS_only / Treatment groups by lineage, cell group, cell type | GATB KIAA0319 CFAP54 CFAP45 LRRC56 ADGRF1 IQCE DNAH1 PLCH1 DNAAF1 ANKFN1 | 3.41e-08 | 198 | 267 | 11 | 6d90b541fde357fbb40f8f7d4e8628a48b679718 |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | ECSCR SPARCL1 DOCK6 HSPG2 FN1 MYCT1 SELENON MAP3K6 ARAP3 PDGFD DCHS1 | 3.59e-08 | 199 | 267 | 11 | da5a88749d859d535daa030d0974485906cc0ba7 |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | SERPING1 SPARCL1 PLEKHH2 COL6A1 SDK2 ANK2 COL6A6 ITSN1 SLC40A1 SDC3 MACF1 | 3.78e-08 | 200 | 267 | 11 | 3bdba9612cd7c612b76aa9abecc4a6529aabfc1c |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | DCC SPARCL1 PLEKHH2 COL6A1 FN1 ANK2 COL6A6 VCAN PDGFD MACF1 ATP2B1 | 3.78e-08 | 200 | 267 | 11 | bd8cf33502adea320e91ca2af14e1911d88ad374 |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Rectal_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | NCOA6 PHF20 LRRC37A3 COL12A1 FN1 RALGAPB SALL4 VCAN WBP4 USPL1 | 1.30e-07 | 178 | 267 | 10 | edc76b8f15056ec1c9a1c61a048b6331a92592d6 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | DCC DSCAML1 USH2A PCDH10 FAT4 COL12A1 PCLO SALL4 DNAH1 PLCH1 | 1.77e-07 | 184 | 267 | 10 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | DCC DSCAML1 USH2A PCDH10 FAT4 COL12A1 PCLO SALL4 DNAH1 PLCH1 | 1.77e-07 | 184 | 267 | 10 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | DCC DSCAML1 USH2A PCDH10 FAT4 COL12A1 PCLO SALL4 DNAH1 PLCH1 | 1.77e-07 | 184 | 267 | 10 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L3-4_RORB_RPS3P6|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | POU6F2 JDP2 DCC CMYA5 PLEKHH2 USH2A COL6A1 FAT4 SLC35F4 PLCH1 | 1.86e-07 | 185 | 267 | 10 | 10da5c2a92bfb3248d3f6f94a0933996326cf590 |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | DCC PLEKHH2 COL6A1 SDK2 ANK2 COL6A6 VCAN PDGFD SETBP1 PLXNA4 | 2.50e-07 | 191 | 267 | 10 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | NCKAP5 DCC PGR SPARCL1 PLEKHH2 FN1 FAM13C SLC40A1 SETBP1 ASTN1 | 2.50e-07 | 191 | 267 | 10 | fa380a8752de158974b2ae5e741573439719cc0d |
| ToppCell | Control-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | NCKAP5 FRMD4B SPARCL1 PLEKHH2 FLNA SDK2 FN1 COL6A6 SLC40A1 MACF1 | 2.76e-07 | 193 | 267 | 10 | 5896242f713ae5fd1a4ebb63827f15d7279dced2 |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | DCC PGR SPARCL1 PLEKHH2 COL6A1 FN1 COL6A6 SLC40A1 SETBP1 MACF1 | 2.89e-07 | 194 | 267 | 10 | 71d3c7448b1734de54187f902f65649f9283bd4c |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MAP1B ASH1L SYT13 COL6A6 PCLO PPP1R1A NISCH MACF1 SRRM2 ATP2B1 | 3.03e-07 | 195 | 267 | 10 | 7796ea9247f4c63762f0de8490fed08b9717fa23 |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MAP1B ASH1L SYT13 COL6A6 PCLO PPP1R1A NISCH MACF1 SRRM2 ATP2B1 | 3.03e-07 | 195 | 267 | 10 | 3e519cffa6144a62b06124642a14c9ff39b76554 |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | FRMD4B SPARCL1 PLEKHH2 COL6A1 FAT4 FN1 COL6A6 SLC40A1 VCAN MACF1 | 3.18e-07 | 196 | 267 | 10 | 1450cb69c5bf469e97c03bf1890f6f7c54165b8a |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | FRMD4B SPARCL1 PLEKHH2 COL6A1 FAT4 FN1 COL6A6 SLC40A1 VCAN MACF1 | 3.33e-07 | 197 | 267 | 10 | 11a4c417f035e554431a8f03be13b5eefa3530c0 |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 3.33e-07 | 197 | 267 | 10 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | IL11 SERPING1 PLEKHH2 COL6A1 SDK2 COL6A6 ITSN1 VCAN PDGFD SDC3 | 3.65e-07 | 199 | 267 | 10 | 06a7d874ff7c4616577f6e59d3118717a8c47c00 |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.65e-07 | 199 | 267 | 10 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_IV-2|World / Primary Cells by Cluster | MAP1B CEP170 DRAXIN PCDH10 CACNA1E ANK2 PCLO APC CMIP ATP2B1 | 3.65e-07 | 199 | 267 | 10 | f09b40245d3d826275bbe5f508dedccc75a911bd |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | IL11 SERPING1 PLEKHH2 COL6A1 SDK2 COL6A6 ITSN1 VCAN PDGFD SDC3 | 3.65e-07 | 199 | 267 | 10 | ba586690f88fd051f449753bfe7603a2cb431782 |
| ToppCell | Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | FAM114A1 MAP1A SERPING1 SPARCL1 HSPG2 COL6A1 FN1 ANK2 VCAN PDGFD | 3.65e-07 | 199 | 267 | 10 | 40de6d4a31cf22efa2864f79e4ec8e2b7bfc9d4a |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_IV|World / Primary Cells by Cluster | MAP1B CEP170 DRAXIN PCDH10 CACNA1E ANK2 PCLO APC CMIP ATP2B1 | 3.65e-07 | 199 | 267 | 10 | e45448ec4db8875c8aaa9aad109a10e2905a4226 |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | SERPING1 PLEKHH2 COL6A1 FAT4 COL12A1 FN1 ANK2 COL6A6 SLC40A1 VCAN | 3.83e-07 | 200 | 267 | 10 | a4ec0e80f5422b91b85264a9bb74568dd577e285 |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Intermediate|5w / Sample Type, Dataset, Time_group, and Cell type. | POU6F2 GATAD2B CEP170 HECTD4 CAMSAP3 PPP1R1A CMIP PLXNA4 SDC3 EIF4G3 | 3.83e-07 | 200 | 267 | 10 | c92e4fc0442404481fcac623d691dae6215b852d |
| ToppCell | Substantia_nigra-Neuronal-Excitatory|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 5.77e-07 | 118 | 267 | 8 | 9f1d744f46d79ff2ab7f168f54fdbd9f4640dddd | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell|Adult / Lineage, Cell type, age group and donor | MAP1B KCNH2 SPARCL1 NOTCH3 COL6A1 FLNA FAM13C PLEKHG3 SETBP1 | 1.01e-06 | 172 | 267 | 9 | c62cad0f4212d1e9ea1ec3143ad3c4e06aff0ebf |
| ToppCell | LPS-IL1RA-Endothelial-Epi-like-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.01e-06 | 127 | 267 | 8 | 6b24630978eb0772b4cd3bf59e5bc4390be47619 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-06 | 179 | 267 | 9 | 025d414ec88d5680d99c8173e70ee3bb0b694f74 | |
| ToppCell | AT1_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 1.41e-06 | 179 | 267 | 9 | 1603117b52623663458a977c94bf7f9f6c1114b8 | |
| ToppCell | Control-Fibroblasts-Airway_smooth_muscle|Control / group, cell type (main and fine annotations) | 1.47e-06 | 180 | 267 | 9 | d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Pecam____fenestrated_capillary_endothelial|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-06 | 180 | 267 | 9 | 79c5725f02e038d0187f4a1e1591f2492538aa57 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.47e-06 | 180 | 267 | 9 | f2f6e83127a4a415e65c76a35efa8175fbd5b5d9 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l6-17|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | MAGI1 KCNH2 ECSCR SPARCL1 NOTCH3 PCDHGA10 MYCT1 ARAP3 PLEKHO1 | 1.47e-06 | 180 | 267 | 9 | 455d1e3ccf2ab609954f3b870e8f514ddca735f4 |
| ToppCell | droplet-Lung-3m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | CASTOR1 ECSCR HSPG2 MYCT1 CAMSAP3 PCDHB4 PDGFD PLXNA4 ATP2B4 | 1.54e-06 | 181 | 267 | 9 | 2c44c41b4e8a75ebdbaeb0c6cc5a03f17c44758c |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma-3|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.60e-06 | 135 | 267 | 8 | 3351e8b9e417397c5fa9f856184ff24ce1a27242 | |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 2.02e-06 | 187 | 267 | 9 | 464a0c3b92b778911b5f9cd73642e09e3472063a | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.11e-06 | 188 | 267 | 9 | a91443aa8fa8fa87f7501c59219daa0305bd0bbf | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.20e-06 | 189 | 267 | 9 | 63449d9f1e78ff2bc8786eb88a0d177fe30c7f4d | |
| ToppCell | moderate-Lymphoid-NK|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.20e-06 | 189 | 267 | 9 | 22a19365782003c18ec8dddcdbfdaa82c4e330f6 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 2.20e-06 | 189 | 267 | 9 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal-fibroblast|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.40e-06 | 191 | 267 | 9 | 9214655dca96d766737c9f30b624d7fe7050342e | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.51e-06 | 192 | 267 | 9 | 3d0cb19f037f604253d7d728689aeaa94251e92b | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-myocytic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.61e-06 | 193 | 267 | 9 | a402e736440684ebe123673b6b0c6fcd8fa057b2 | |
| ToppCell | Posterior_cortex-Neuronal|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.61e-06 | 193 | 267 | 9 | b4989e3436e84dbec3789b46057e0f7a0ebf09d4 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.73e-06 | 194 | 267 | 9 | 5f5f0cdeacd5e1b28717d78dabdb9eb95f661e36 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.73e-06 | 194 | 267 | 9 | 8c37bedb23285735ff3828db3889897fada8c95d | |
| ToppCell | 356C-Epithelial_cells-Epithelial-I_(AT1)|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.85e-06 | 195 | 267 | 9 | 07a3ef6b0f1201fe2bcb9ea426b8f7a69beb4904 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-I_(AT1)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.85e-06 | 195 | 267 | 9 | b65511770ed67f7447847e2187555b362988af45 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.85e-06 | 195 | 267 | 9 | 1cdf5f296029ae424d9dba42e86a6d111e4896e6 | |
| ToppCell | PCW_05-06-Mesenchymal|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.97e-06 | 196 | 267 | 9 | dca52c57ba35d9395cdbca8b881f12ece721b10f | |
| ToppCell | Epithelial_cells-AT1_cells|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 2.97e-06 | 196 | 267 | 9 | 6c99d29162848161c1f166a032320f87a5d5a631 | |
| ToppCell | 15-Trachea-Mesenchymal|Trachea / Age, Tissue, Lineage and Cell class | 2.97e-06 | 196 | 267 | 9 | 7e178c76285e61c721c38d7a995ebf89dc428f9f | |
| ToppCell | LPS_IL1RA_TNF|World / Treatment groups by lineage, cell group, cell type | SCNN1A SERPING1 SPARCL1 PLEKHH2 SYT13 COL6A1 COL6A6 SLC40A1 VCAN | 3.09e-06 | 197 | 267 | 9 | 0a6550dce156fc81f15b1e7830d331ca50d87d06 |
| ToppCell | 10x3'2.3-week_17-19-Endothelial-stroma-tip_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.09e-06 | 197 | 267 | 9 | b212ff28ca2d1fea4140f186ab90941bdca21249 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_neuro-secretory-Neuroendocrine|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.09e-06 | 197 | 267 | 9 | 3a0e97bfebe82f9687d518baaad7f20d0ffea8a1 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated-Deuterosomal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | LRRC37A3 MCIDAS CFAP54 LRRC37A CFAP45 DNAH1 PLCH1 DNAAF1 ATP2B3 | 3.09e-06 | 197 | 267 | 9 | 6e4a411ef823ce9e16f420e185e21fa19d13af34 |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.09e-06 | 197 | 267 | 9 | bf0520a94ebb1d2f94de9f526d17e0b0e8fe7052 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Mesothelial-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | MAP1B DBNDD2 LRRC56 SPARCL1 PCDH10 COL6A1 ANK2 AKNAD1 FAM72B | 3.22e-06 | 198 | 267 | 9 | 2dc0510846cbc296a300b8465e7be9b39f479852 |
| ToppCell | 10x3'2.3-week_17-19-Endothelial|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.22e-06 | 198 | 267 | 9 | 2630a7a6e56febe5c0b0bde70dd7292fa1650c47 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Mesothelial-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | MAP1B DBNDD2 LRRC56 SPARCL1 PCDH10 COL6A1 ANK2 AKNAD1 FAM72B | 3.22e-06 | 198 | 267 | 9 | eb7e674d08a7aeb554c1e4797338280581b79989 |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 3.22e-06 | 198 | 267 | 9 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.22e-06 | 198 | 267 | 9 | 17dc055e2a289496d9c5cdbf3297bdf906dc6d22 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Mesothelial-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | MAP1B DBNDD2 LRRC56 SPARCL1 PCDH10 COL6A1 ANK2 AKNAD1 FAM72B | 3.22e-06 | 198 | 267 | 9 | 364de83e30d842123fb92367f54b4bea57a47c84 |
| ToppCell | 10x3'2.3-week_17-19-Endothelial-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.22e-06 | 198 | 267 | 9 | 1e83bec16dcd60460422625f89952ff506d6be51 | |
| ToppCell | stromal_cell-stromal_cell|World / Lineage and Cell class | SERPING1 ACSM5 SPARCL1 NOTCH3 COL6A1 ANK2 FAM13C EPB41L4B COL28A1 | 3.36e-06 | 199 | 267 | 9 | 74262363a34da3a1eb55ab375fd61ddd7bb39b23 |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.36e-06 | 199 | 267 | 9 | 8b62d43af8b2ebb4c1b2d068d50beaf35728dbe7 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Macrophage_alveolar-Macro_alv_dividing|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.36e-06 | 199 | 267 | 9 | c6d59ed26eadd3c41acfe1b4d929270e00ea3e95 | |
| ToppCell | 18-Distal-Mesenchymal-Mesenchyme_RSPO2+|Distal / Age, Tissue, Lineage and Cell class | 3.36e-06 | 199 | 267 | 9 | 95403988caef322314f4ed15415ad1a9a987adc1 | |
| ToppCell | stromal_cell|World / Lineage and Cell class | SERPING1 ACSM5 SPARCL1 NOTCH3 COL6A1 ANK2 FAM13C EPB41L4B COL28A1 | 3.36e-06 | 199 | 267 | 9 | 507a82d0529b5b1fa5aebcfe43db53f0b6e3f8f0 |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.36e-06 | 199 | 267 | 9 | c007cd51577e31553395ceaed70ad447e5854546 | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.36e-06 | 199 | 267 | 9 | e6715288a586631676722f2323f0d833431161cf | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.50e-06 | 200 | 267 | 9 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | SPARCL1 PLEKHH2 COL6A1 FAT4 SDK2 COL6A6 SLC40A1 SETBP1 MACF1 | 3.50e-06 | 200 | 267 | 9 | aa1a35dcca3b799241eef4237f6eb94660e019f0 |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.50e-06 | 200 | 267 | 9 | b1be27d134a8633e3e7862c6a0d7be2001d387f0 | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-4-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.50e-06 | 200 | 267 | 9 | 4dbe21cb63569f28c7017cda065ea5ee00d7254e | |
| ToppCell | Control_saline-Endothelial-Endothelial-Gen_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 3.50e-06 | 200 | 267 | 9 | 3b97920e1e6e2f09ddba2a861baa9c00c2970f4c | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | SPARCL1 PLEKHH2 COL6A1 FAT4 SDK2 COL6A6 SLC40A1 SETBP1 MACF1 | 3.50e-06 | 200 | 267 | 9 | a510deaada669e690329183e18df02870bd204b3 |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-4|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.50e-06 | 200 | 267 | 9 | 8256511b099c3eab8e33194f90c9ff354e7cfe8e | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer|World / Primary Cells by Cluster | 3.50e-06 | 200 | 267 | 9 | db10f76938af553d1a2275bb02ef75dff3c3135b | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.50e-06 | 200 | 267 | 9 | 2e47888e041ec3d265425d1df97b6665c6da889c | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer-21|World / Primary Cells by Cluster | 3.50e-06 | 200 | 267 | 9 | 30a3e4aee12ec1b5acdce90f86c9733c27a7f6fc | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.50e-06 | 200 | 267 | 9 | ced14d83222dbebca85c40540e76824e683354f3 | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-3|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | SERPING1 SPARCL1 PLEKHH2 COL6A1 COL12A1 FN1 ANK2 SLC40A1 VCAN | 3.50e-06 | 200 | 267 | 9 | e663995fc44c340d878d66b278b7b5c2ff784301 |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.50e-06 | 200 | 267 | 9 | a637281d91e95734ee4f8510b3780e0272b16fda | |
| ToppCell | LPS_only-Endothelial-Endothelial-Gen_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | NCKAP5 SERPING1 SPARCL1 DOCK6 FAT4 ARHGEF12 ARAP3 MACF1 PLEKHO1 | 3.50e-06 | 200 | 267 | 9 | eb94a5111ef0e903ee5be9f7efe571b4e6d5fce1 |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteochondral_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | MAP1B SERPING1 SPARCL1 PLEKHH2 NOTCH3 COL6A1 COL12A1 FN1 SALL4 | 3.50e-06 | 200 | 267 | 9 | ad3fb8ef0be45032369d1325024787fbe1dfb8d6 |
| ToppCell | Parenchyma_COVID-19-Stromal-TX-Fibroblasts-4|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 3.50e-06 | 200 | 267 | 9 | bde938e5a18844fb8cc1d1be5a086809f7e2b97d | |
| Drug | Medrysone [2668-66-8]; Down 200; 11.6uM; MCF7; HT_HG-U133A | MAGI1 KDM4C PGR DOCK6 TAT PCLO APC PCDHA5 SETD2 PLCH1 EIF4G3 TOPORS HCFC1 | 5.51e-07 | 194 | 268 | 13 | 4727_DN |
| Drug | 1sqc | 3.73e-06 | 10 | 268 | 4 | CID000444279 | |
| Drug | 2brh | 3.80e-06 | 21 | 268 | 5 | CID000848641 | |
| Drug | Ceftazidime pentahydrate [78439-06-2]; Down 200; 6.2uM; MCF7; HT_HG-U133A | MAGI1 PHF20 TRAIP TBC1D9 PAN2 BTBD2 ERN2 GSTT1 ZNF408 SPIDR PLEKHO1 ZNF654 | 4.53e-06 | 199 | 268 | 12 | 5473_DN |
| Drug | Tamoxifen citrate [54965-24-1]; Up 200; 7uM; PC3; HT_HG-U133A | ALKBH4 MYRF TAT IQCE IMPG2 ARHGEF12 ERN2 MLH3 ABCB9 VCAN GGA1 HCFC1 | 4.53e-06 | 199 | 268 | 12 | 2050_UP |
| Drug | lanthanum | TRPC5 PTK2B PKD1 CACNA1E CACNB4 CASR ATP2B1 ATP2B2 ATP2B3 ATP2B4 | 5.00e-06 | 136 | 268 | 10 | CID000023926 |
| Drug | 2,5-dimethylquinone | 5.80e-06 | 11 | 268 | 4 | CID000008718 | |
| Drug | 1vyq | 8.63e-06 | 12 | 268 | 4 | CID004369390 | |
| Drug | Ro 46861 | 8.63e-06 | 12 | 268 | 4 | CID000003128 | |
| Drug | cyhexatin | 9.54e-06 | 25 | 268 | 5 | CID005364545 | |
| Drug | UTP-NA | TRPC5 PTK2B NOP9 TONSL PLCB3 CX3CL1 FLNA APC MUC12 PPAT ROCK1 CARD11 PLCH1 ATP2B1 ATP2B2 ATP2B3 ATP2B4 | 1.12e-05 | 420 | 268 | 17 | CID000001181 |
| Drug | 8-hydroxycoumarin | 1.23e-05 | 13 | 268 | 4 | CID000122783 | |
| Drug | p-hydroxyhippuric acid | 1.71e-05 | 14 | 268 | 4 | CID000151012 | |
| Drug | Chelidonine monohydrate (+) [476-32-4]; Up 200; 10.8uM; MCF7; HT_HG-U133A | ATAD5 MPDZ FOCAD CLCN5 SCNN1A CSTF2T FLNA ITSN1 ARHGEF12 PLCH1 PLEKHO1 | 1.75e-05 | 191 | 268 | 11 | 6236_UP |
| Drug | Econazole nitrate [24169-02-6]; Down 200; 9uM; MCF7; HT_HG-U133A | ZHX3 PLCB3 PRR14L ITSN1 APC ARHGEF12 SETD2 RAB11FIP5 PLCH1 SRRM2 ATP2B4 | 1.83e-05 | 192 | 268 | 11 | 7427_DN |
| Drug | Idoxuridine [54-42-2]; Down 200; 11.2uM; MCF7; HT_HG-U133A | ALKBH4 IL11 TBC1D9B ATAD5 PLCB3 PRR14L DOCK6 PLXNB1 HSPG2 ITSN1 PLEKHG3 | 2.02e-05 | 194 | 268 | 11 | 1480_DN |
| Drug | Aspartic acid, N-acetyl (R,S) [997-55-7]; Down 200; 22.8uM; MCF7; HT_HG-U133A | ZHX3 PHF20 FRMD4B CLCN5 PRR14L DAGLA COL6A1 ERN2 THOC5 GGA1 HCFC1 | 2.22e-05 | 196 | 268 | 11 | 4125_DN |
| Drug | PF-00539745-00 [351321-33-0]; Up 200; 10uM; PC3; HT_HG-U133A | MAGI1 ZHX3 KDM4C DOCK6 ADGRF1 MYRF DAGLA ERN2 VCAN SENP6 GGA1 | 2.22e-05 | 196 | 268 | 11 | 5979_UP |
| Drug | Sulfaphenazole [526-08-9]; Down 200; 12.8uM; MCF7; HT_HG-U133A | ALKBH4 TBC1D9B TBC1D9 ZNF282 IMPG2 FN1 APC TUT1 PPP4R3A SRRM2 PLEKHO1 | 2.33e-05 | 197 | 268 | 11 | 5507_DN |
| Drug | Cytisine (-) [485-35-8]; Down 200; 21uM; MCF7; HT_HG-U133A | TRAIP GATB CLCN5 NOTCH3 FN1 MLH3 PLEKHG3 EIF4G3 DNAAF1 GGA1 PLEKHO1 | 2.33e-05 | 197 | 268 | 11 | 6217_DN |
| Drug | Demeclocycline hydrochloride [64-73-3]; Down 200; 8uM; HL60; HT_HG-U133A | ALKBH4 KDM4C ATAD5 DBNDD2 CEP97 APC ERN2 THOC5 MLH3 ARAP3 ZNF408 | 2.33e-05 | 197 | 268 | 11 | 2545_DN |
| Drug | Allantoin [97-59-6]; Up 200; 25.2uM; MCF7; HT_HG-U133A | IL11 PHF20 KDM4C TRMT13 DOCK6 ITSN1 ERN2 PPP4R3A SETD2 ABCB9 ATP2B4 | 2.33e-05 | 197 | 268 | 11 | 1678_UP |
| Drug | Letrozole [112809-51-5]; Down 200; 14uM; MCF7; HT_HG-U133A | ZHX3 KDM4C TRAIP TRMT13 ARMH3 APC ERN2 PPP4R3A ABCB9 SDC3 SPIDR | 2.68e-05 | 200 | 268 | 11 | 7336_DN |
| Drug | NSC3056 | 3.66e-05 | 137 | 268 | 9 | CID000001599 | |
| Drug | AC1L88YH | 3.96e-05 | 17 | 268 | 4 | CID000374551 | |
| Drug | AC1L1KS5 | TRPC5 NOP9 PKD1 PLCB3 DAGLA CACNA1E CACNB4 FPR3 ROCK1 PLCH1 ATP2B1 ATP2B2 ATP2B3 ATP2B4 | 4.60e-05 | 334 | 268 | 14 | CID000005631 |
| Drug | i1-3 | 5.45e-05 | 7 | 268 | 3 | CID001971814 | |
| Drug | gramicidin s | 6.97e-05 | 37 | 268 | 5 | CID000073357 | |
| Drug | milrinone | 7.42e-05 | 150 | 268 | 9 | CID000004197 | |
| Drug | mercury | PPRC1 F5 CDAN1 KCNH2 TONSL PKD1 CACNA1E CACNB4 LILRA2 FN1 DNAH1 SENP6 CARD11 USPL1 ATP2B1 ATP2B2 ATP2B3 ATP2B4 | 8.33e-05 | 542 | 268 | 18 | CID000023931 |
| Drug | FIGLU | 9.03e-05 | 39 | 268 | 5 | CID000000909 | |
| Drug | Metampicillin sodium salt [6489-61-8]; Up 200; 10.4uM; PC3; HT_HG-U133A | 9.78e-05 | 192 | 268 | 10 | 2123_UP | |
| Drug | Quercetine dihydrate [6151-25-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A | ATAD5 MPDZ KCNH2 PLCB3 IQCE ITSN1 RALGAPB PLEKHG3 HCFC1 ZNF654 | 1.02e-04 | 193 | 268 | 10 | 4846_DN |
| Drug | Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.02e-04 | 193 | 268 | 10 | 6981_DN | |
| Drug | Oxymetazoline hydrochloride [2315-02-8]; Up 200; 13.4uM; PC3; HT_HG-U133A | MAP1B ZBTB40 CSTF2T NOTCH3 APC ERN2 ABCB9 DNAAF1 SRRM2 ATP2B2 | 1.07e-04 | 194 | 268 | 10 | 2114_UP |
| Drug | Bambuterol hydrochloride [81732-46-9]; Down 200; 10uM; MCF7; HT_HG-U133A | KDM4C ATAD5 ZBTB40 CEP97 TUT1 MAP3K6 TRIM33 RAB11FIP5 DNAAF1 SRRM2 | 1.11e-04 | 195 | 268 | 10 | 7239_DN |
| Drug | Dimethisoquin hydrochloride [2773-92-4]; Down 200; 13uM; HL60; HT_HG-U133A | 1.11e-04 | 195 | 268 | 10 | 2151_DN | |
| Drug | azathioprine, USP; Up 200; 100uM; MCF7; HG-U133A | 1.11e-04 | 195 | 268 | 10 | 338_UP | |
| Drug | Budesonide [51333-22-3]; Up 200; 9.2uM; PC3; HT_HG-U133A | KDM4C ASH1L SLC22A14 CFAP45 SCNN1A COL6A1 PLEKHG3 DEPDC5 PLCH1 HCFC1 | 1.11e-04 | 195 | 268 | 10 | 6330_UP |
| Drug | Morantel tartrate [26155-31-7]; Up 200; 10.8uM; HL60; HT_HG-U133A | 1.16e-04 | 196 | 268 | 10 | 1840_UP | |
| Drug | Praziquantel [55268-74-1]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 1.16e-04 | 196 | 268 | 10 | 7228_DN | |
| Drug | Aceclofenac [89796-99-6]; Up 200; 11.2uM; PC3; HT_HG-U133A | CSTF2T PLXNB1 NOTCH3 IQCE APC THOC5 PPP4R3A SPIDR PLEKHO1 HCFC1 | 1.16e-04 | 196 | 268 | 10 | 7269_UP |
| Drug | doxycycline; Down 200; 14.4uM; MCF7; HT_HG-U133A_EA | 1.16e-04 | 196 | 268 | 10 | 1113_DN | |
| Drug | Perhexiline maleate [6724-53-4]; Down 200; 10.2uM; PC3; HT_HG-U133A | TBC1D9B PHF20 ATAD5 ASH1L VPS35L DOCK6 ADGRF1 FAT4 ARHGEF12 SENP6 | 1.16e-04 | 196 | 268 | 10 | 5081_DN |
| Drug | Denatonium benzoate [3734-33-6]; Down 200; 9uM; PC3; HT_HG-U133A | IL11 PHF20 DOCK6 CSTF2T PLXNB1 NOTCH3 FAT4 APC ARHGEF12 MLH3 | 1.16e-04 | 196 | 268 | 10 | 5061_DN |
| Drug | fluphenazine dihydrochloride; Down 200; 10uM; PC3; HT_HG-U133A | 1.21e-04 | 197 | 268 | 10 | 4461_DN | |
| Drug | Tubocurarine chloride pentahydrate (+) [6989-98-6]; Down 200; 5.2uM; MCF7; HT_HG-U133A | MAGI1 CSTF2T IQCE TUT1 BTBD2 ZNF408 RAB11FIP5 SPIDR GGA1 PLEKHO1 | 1.21e-04 | 197 | 268 | 10 | 5449_DN |
| Drug | Demeclocycline hydrochloride [64-73-3]; Down 200; 8uM; MCF7; HT_HG-U133A | 1.21e-04 | 197 | 268 | 10 | 3404_DN | |
| Drug | Tinidazole [19387-91-8]; Up 200; 16.2uM; HL60; HT_HG-U133A | MAGI1 POU6F2 CLCN5 CX3CL1 IMPG2 COL6A1 EPYC VCAN PLCH1 HCFC1 | 1.21e-04 | 197 | 268 | 10 | 2568_UP |
| Drug | Alprostadil [745-65-3]; Down 200; 11.2uM; MCF7; HT_HG-U133A | ATAD5 TRAIP KCNH2 ARHGEF12 PPP4R3A GSTT1 ABCB9 SDC3 RAB11FIP5 HCFC1 | 1.21e-04 | 197 | 268 | 10 | 7358_DN |
| Drug | Cyproterone acetate [427-51-0]; Down 200; 9.6uM; MCF7; HT_HG-U133A | MAGI1 ZHX3 CLCN5 ARMH3 CSTF2T IQCE MAP3K6 ABCB9 PLEKHG3 PLCH1 | 1.21e-04 | 197 | 268 | 10 | 3545_DN |
| Drug | Tracazolate hydrochloride [41094-88-6]; Up 200; 11.8uM; PC3; HT_HG-U133A | 1.21e-04 | 197 | 268 | 10 | 6619_UP | |
| Drug | Furosemide [54-31-9]; Down 200; 12uM; PC3; HT_HG-U133A | 1.21e-04 | 197 | 268 | 10 | 4503_DN | |
| Drug | Ioversol [87771-40-2]; Up 200; 5uM; MCF7; HT_HG-U133A | 1.21e-04 | 197 | 268 | 10 | 3365_UP | |
| Drug | Sulfameter [651-06-9]; Up 200; 14.2uM; MCF7; HT_HG-U133A | 1.21e-04 | 197 | 268 | 10 | 3453_UP | |
| Drug | Monensin sodium salt [22373-78-0]; Down 200; 5.8uM; MCF7; HT_HG-U133A | TBC1D9B TRAIP ZBTB40 DOCK6 TUT1 SETD2 CBX6 PLCH1 GGA1 PLEKHO1 | 1.21e-04 | 197 | 268 | 10 | 3443_DN |
| Drug | Reserpinic acid hydrochloride; Down 200; 9.2uM; MCF7; HT_HG-U133A | KCNH2 CEP97 PLXNB1 PPP4R3A GSTT1 ABCB9 SDC3 MACF1 PLCH1 EIF4G3 | 1.26e-04 | 198 | 268 | 10 | 7323_DN |
| Drug | Tracazolate hydrochloride [41094-88-6]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 1.26e-04 | 198 | 268 | 10 | 4964_UP | |
| Drug | Bacitracin [1405-87-4]; Down 200; 2.8uM; MCF7; HT_HG-U133A | KCNH2 PRR14L ARMH3 CSTF2T ARHGEF12 MAP3K6 MLH3 ABCB9 PDGFD HCFC1 | 1.26e-04 | 198 | 268 | 10 | 6488_DN |
| Drug | Isometheptene mucate; Down 200; 8.2uM; MCF7; HT_HG-U133A | 1.26e-04 | 198 | 268 | 10 | 6524_DN | |
| Drug | Torsemide [56211-40-6]; Down 200; 11.4uM; MCF7; HT_HG-U133A | ALKBH4 MAGI1 FN1 APC ARHGEF12 MAP3K6 SETD2 PLEKHG3 SRRM2 PLEKHO1 | 1.26e-04 | 198 | 268 | 10 | 5476_DN |
| Drug | Protriptyline hydrochloride [1225-55-4]; Down 200; 13.4uM; MCF7; HT_HG-U133A | MAGI1 TRAIP TBC1D9 CSTF2T COL6A1 GSTT1 ABCB9 PDGFD SDC3 SPIDR | 1.26e-04 | 198 | 268 | 10 | 6498_DN |
| Drug | Mebendazole [31431-39-7]; Down 200; 13.6uM; MCF7; HT_HG-U133A | 1.26e-04 | 198 | 268 | 10 | 4694_DN | |
| Drug | Fenofibrate [49562-28-9]; Down 200; 11uM; HL60; HT_HG-U133A | ATAD5 TRAIP F5 SLC22A14 LILRA2 MLH3 ZNF408 VCAN DEPDC5 HCFC1 | 1.26e-04 | 198 | 268 | 10 | 2401_DN |
| Drug | Fenspiride hydrochloride [5053-08-7]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 1.26e-04 | 198 | 268 | 10 | 2269_UP | |
| Drug | Benzthiazide [91-33-8]; Down 200; 9.2uM; HL60; HT_HG-U133A | TRPC5 DOCK6 DAGLA TAT HSPG2 CACNB4 LILRA2 THOC5 PLEKHG3 ZNF408 | 1.26e-04 | 198 | 268 | 10 | 2989_DN |
| Drug | Foliosidine [2520-38-9]; Up 200; 13uM; MCF7; HT_HG-U133A | POU6F2 PTK2B KCNH2 COL6A1 CASR THOC5 RAB11FIP5 PLCH1 ATP2B3 ATP2B4 | 1.26e-04 | 198 | 268 | 10 | 4761_UP |
| Drug | Acenocoumarol [152-72-7]; Down 200; 11.4uM; PC3; HT_HG-U133A | 1.26e-04 | 198 | 268 | 10 | 5878_DN | |
| Drug | Troleandomycin [2751-09-9]; Up 200; 5uM; MCF7; HT_HG-U133A | 1.26e-04 | 198 | 268 | 10 | 1465_UP | |
| Drug | calmidazolium chloride; Down 200; 5uM; MCF7; HG-U133A | 1.26e-04 | 198 | 268 | 10 | 486_DN | |
| Drug | Ticlopidine hydrochloride [53885-35-1]; Down 200; 13.4uM; PC3; HT_HG-U133A | IL11 TBC1D9 PLCB3 COL6A1 ITSN1 ARHGEF12 PPP4R3A ABCB9 VCAN PLEKHO1 | 1.26e-04 | 198 | 268 | 10 | 4074_DN |
| Drug | wortmannin; Down 200; 0.01uM; ssMCF7; HG-U133A | 1.31e-04 | 199 | 268 | 10 | 404_DN | |
| Drug | Levocabastine hydrochloride [79547-78-7]; Down 200; 8.8uM; MCF7; HT_HG-U133A | TBC1D9 ZBTB40 TRMT13 ITSN1 ARHGEF12 TRIM33 SETD2 TOPORS ATP2B4 ZNF654 | 1.31e-04 | 199 | 268 | 10 | 7009_DN |
| Drug | Aztreonam [78110-38-0]; Down 200; 9.2uM; MCF7; HT_HG-U133A | CLCN5 DOCK6 COL6A1 TUT1 ERN2 SETD2 ABCB9 SPIDR PLCH1 PLEKHO1 | 1.31e-04 | 199 | 268 | 10 | 5535_DN |
| Drug | Nicergoline; Down 200; 8.2uM; MCF7; HT_HG-U133A | 1.31e-04 | 199 | 268 | 10 | 2220_DN | |
| Drug | benserazide hydrochloride; Up 200; 10uM; MCF7; HG-U133A | ZNF131 YJU2B PAN2 HOOK2 ZNF282 ITSN1 PPP4R3A ZNF408 SDC3 MTRR | 1.31e-04 | 199 | 268 | 10 | 641_UP |
| Drug | Chenodiol [474-25-9]; Down 200; 10.2uM; HL60; HT_HG-U133A | 1.31e-04 | 199 | 268 | 10 | 2402_DN | |
| Drug | Ketoprofen [22071-15-4]; Up 200; 15.8uM; MCF7; HT_HG-U133A | 1.31e-04 | 199 | 268 | 10 | 3626_UP | |
| Drug | Flucytosine [2022-85-7]; Up 200; 31uM; PC3; HT_HG-U133A | IL11 MAGI1 TRPC5 CSTF2T FAM13C CASR PCDHA5 VCAN ASTN1 DEPDC5 | 1.31e-04 | 199 | 268 | 10 | 6690_UP |
| Drug | Metrizamide [31112-62-6]; Down 200; 5uM; PC3; HT_HG-U133A | 1.37e-04 | 200 | 268 | 10 | 4075_DN | |
| Drug | Carbenoxolone disodium salt [7421-40-1]; Down 200; 6.6uM; HL60; HT_HG-U133A | MAP1A CFAP45 COL6A1 FN1 CASR TUT1 THOC5 PLEKHG3 DNAAF1 ATP2B2 | 1.37e-04 | 200 | 268 | 10 | 3014_DN |
| Drug | Letrozole [112809-51-5]; Down 200; 14uM; MCF7; HT_HG-U133A | MAP1B ZBTB40 PLCB3 CEP97 COL6A1 APC ERN2 TRIM33 SPIDR DNAAF1 | 1.37e-04 | 200 | 268 | 10 | 4824_DN |
| Drug | 3-Acetylcoumarin [3949-36-8]; Up 200; 21.2uM; HL60; HT_HG-U133A | DBNDD2 MPDZ SLC22A14 NOTCH3 COL6A1 CACNB4 PCLO CASR CFAP43 ATP2B2 | 1.37e-04 | 200 | 268 | 10 | 3044_UP |
| Drug | caloxin 1b1 | 1.38e-04 | 2 | 268 | 2 | ctd:C510327 | |
| Drug | Bp-7,8,9,10-tetrol | 1.38e-04 | 2 | 268 | 2 | CID000115324 | |
| Drug | NSC154853 | 1.38e-04 | 2 | 268 | 2 | CID000290703 | |
| Drug | AC1L25Y6 | 1.39e-04 | 23 | 268 | 4 | CID000015465 | |
| Drug | lanthanum chloride hydrate | 1.39e-04 | 23 | 268 | 4 | CID000165791 | |
| Drug | linopirdine | 1.45e-04 | 43 | 268 | 5 | CID000003932 | |
| Drug | AC1MU1S9 | PTK2B TONSL PLCB3 HSF1 CX3CL1 DAGLA FLNA FPR3 SETD2 PDGFD SETBP1 ROCK1 CARD11 PLCH1 ATP2B1 ATP2B2 ATP2B3 ATP2B4 | 1.63e-04 | 572 | 268 | 18 | CID000003733 |
| Drug | agelasine B | 2.01e-04 | 46 | 268 | 5 | CID006439899 | |
| Drug | cocaethylene | 2.21e-04 | 73 | 268 | 6 | CID000002825 | |
| Drug | dodecyl ether | 2.29e-04 | 26 | 268 | 4 | CID000020667 | |
| Drug | erythromyclamine | 2.29e-04 | 26 | 268 | 4 | CID000083942 | |
| Disease | Hailey-Hailey disease (implicated_via_orthology) | 8.71e-08 | 6 | 260 | 4 | DOID:0050429 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of breast | NCOA6 TBC1D9B MYOD1 LRRC37A2 COG3 FSCB PGR NOP9 LRRC37A NLRC5 PLXNB1 NOTCH3 FLNA FN1 ANK2 MAP3K6 THOC5 SIRT1 SETD2 ARAP3 NISCH SETBP1 WBP4 ANKRD30A FKBPL MACF1 GGA1 | 1.13e-06 | 1074 | 260 | 27 | C0006142 |
| Disease | Colorectal Carcinoma | MAP1B DCC F5 DSCAML1 PAN2 FN1 ANK2 RBP3 APC ZDHHC7 HPS3 PPOX MLH3 ARAP3 PDGFD SETBP1 DCHS1 MTRR | 5.77e-05 | 702 | 260 | 18 | C0009402 |
| Disease | Van Maldergem Wetzburger Verloes syndrome | 7.73e-05 | 2 | 260 | 2 | C1832390 | |
| Disease | Van Maldergem syndrome | 7.73e-05 | 2 | 260 | 2 | cv:C1832390 | |
| Disease | Periventricular gray matter heterotopia | 7.73e-05 | 2 | 260 | 2 | C1849173 | |
| Disease | Neurodevelopmental Disorders | 1.77e-04 | 93 | 260 | 6 | C1535926 | |
| Disease | Heterotopia, Periventricular, Autosomal Recessive | 2.31e-04 | 3 | 260 | 2 | C1842563 | |
| Disease | myeloid white cell count | SH3BP1 PTK2B PKD1 ZNF398 NLRC5 ZNF282 PLXNB1 FBXO34 FN1 TIMD4 MYCT1 HECTD4 ARHGEF12 SPATA32 SETD2 CMIP DOT1L GGA1 ATP2B4 SNX2 | 2.66e-04 | 937 | 260 | 20 | EFO_0007988 |
| Disease | autosomal dominant intellectual developmental disorder (is_implicated_in) | 4.20e-04 | 17 | 260 | 3 | DOID:0060307 (is_implicated_in) | |
| Disease | Ullrich congenital muscular dystrophy 1 | 4.59e-04 | 4 | 260 | 2 | C0410179 | |
| Disease | Bethlem myopathy (is_implicated_in) | 4.59e-04 | 4 | 260 | 2 | DOID:0050663 (is_implicated_in) | |
| Disease | nephrotic syndrome type 20 (implicated_via_orthology) | 4.59e-04 | 4 | 260 | 2 | DOID:0070357 (implicated_via_orthology) | |
| Disease | Ullrich congenital muscular dystrophy | 4.59e-04 | 4 | 260 | 2 | cv:C4551860 | |
| Disease | Bethlem myopathy | 4.59e-04 | 4 | 260 | 2 | cv:C1834674 | |
| Disease | BETHLEM MYOPATHY 1 | 4.59e-04 | 4 | 260 | 2 | C1834674 | |
| Disease | epilepsy (is_marker_for) | 4.59e-04 | 4 | 260 | 2 | DOID:1826 (is_marker_for) | |
| Disease | Ullrich congenital muscular dystrophy (is_implicated_in) | 4.59e-04 | 4 | 260 | 2 | DOID:0050558 (is_implicated_in) | |
| Disease | head and neck cancer (is_implicated_in) | 4.59e-04 | 4 | 260 | 2 | DOID:11934 (is_implicated_in) | |
| Disease | familial atrial fibrillation | 4.86e-04 | 156 | 260 | 7 | C3468561 | |
| Disease | Persistent atrial fibrillation | 4.86e-04 | 156 | 260 | 7 | C2585653 | |
| Disease | Paroxysmal atrial fibrillation | 4.86e-04 | 156 | 260 | 7 | C0235480 | |
| Disease | wellbeing measurement, alcohol consumption measurement | 5.02e-04 | 74 | 260 | 5 | EFO_0007869, EFO_0007878 | |
| Disease | neuroimaging measurement | MAGI1 ZHX3 PDE8A MAP1B NCKAP5 DCC FRMD4B GATAD2B NEO1 CASTOR1 PKD1 PKDCC APC ARHGEF12 SLC40A1 PPP4R3A VCAN PDGFD MACF1 PLCH1 ANKFN1 | 5.59e-04 | 1069 | 260 | 21 | EFO_0004346 |
| Disease | Atrial Fibrillation | 5.65e-04 | 160 | 260 | 7 | C0004238 | |
| Disease | Glioblastoma | 6.77e-04 | 79 | 260 | 5 | C0017636 | |
| Disease | eosinophil count | PDE8A KDM4C MCIDAS JDP2 NACAD PTK2B ZBTB40 ZNF398 NLRC5 PLCB3 CX3CL1 MYRF ZNF282 FLNA FPR3 HECTD4 ZBTB9 CASR ERN2 SETD2 CMIP SDC3 CARD11 SPIDR EIF4G3 ALPK2 | 7.33e-04 | 1488 | 260 | 26 | EFO_0004842 |
| Disease | white matter microstructure measurement | IL11 NCKAP5 DCC FRMD4B CASTOR1 SDK2 PPP4R3A VCAN SETBP1 CARD11 EIF4G3 | 7.43e-04 | 390 | 260 | 11 | EFO_0005674 |
| Disease | Malignant Cystosarcoma Phyllodes | 7.60e-04 | 5 | 260 | 2 | C0600066 | |
| Disease | calcium oxalate nephrolithiasis (is_implicated_in) | 7.60e-04 | 5 | 260 | 2 | DOID:0080652 (is_implicated_in) | |
| Disease | Phyllodes Tumor | 7.60e-04 | 5 | 260 | 2 | C0010701 | |
| Disease | Primary Ciliary Dyskinesia | 7.80e-04 | 47 | 260 | 4 | C4551720 | |
| Disease | DNA methylation | ZHX3 POU6F2 PDE8A DCC PHF2 USH2A PCDH10 FAT4 BPIFB3 COL28A1 SLC35F4 PLXNA4 DCHS1 ATP2B2 ATP2B4 | 7.83e-04 | 656 | 260 | 15 | GO_0006306 |
| Disease | COVID-19 (is_implicated_in) | 8.00e-04 | 21 | 260 | 3 | DOID:0080600 (is_implicated_in) | |
| Disease | level of Phosphatidylcholine (18:1_20:4) in blood serum | 8.00e-04 | 21 | 260 | 3 | OBA_2045104 | |
| Disease | level of Phosphatidylcholine (16:1_18:2) in blood serum | 8.00e-04 | 21 | 260 | 3 | OBA_2045083 | |
| Disease | post-traumatic stress disorder symptom measurement | 8.03e-04 | 82 | 260 | 5 | EFO_0008535 | |
| Disease | Malignant Neoplasms | 9.78e-04 | 128 | 260 | 6 | C0006826 | |
| Disease | verbal-numerical reasoning measurement | 1.10e-03 | 131 | 260 | 6 | EFO_0008394 | |
| Disease | diabetic angiopathy (implicated_via_orthology) | 1.13e-03 | 6 | 260 | 2 | DOID:11713 (implicated_via_orthology) | |
| Disease | BRICHOS domain-containing protein 5 measurement | 1.13e-03 | 6 | 260 | 2 | EFO_0801430 | |
| Disease | Idiopathic generalized epilepsy | 1.13e-03 | 6 | 260 | 2 | C0270850 | |
| Disease | peripheral neuropathy, response to bortezomib | 1.13e-03 | 6 | 260 | 2 | EFO_0003100, EFO_0007808 | |
| Disease | periventricular nodular heterotopia (is_implicated_in) | 1.13e-03 | 6 | 260 | 2 | DOID:0050454 (is_implicated_in) | |
| Disease | gamma-linolenic acid measurement | 1.19e-03 | 24 | 260 | 3 | EFO_0007762 | |
| Disease | Brugada Syndrome (disorder) | 1.19e-03 | 24 | 260 | 3 | C1142166 | |
| Disease | depressive symptom measurement | ZHX3 POU6F2 DCC PHF2 ZBTB37 DAGLA CACNA1E PCLO PCDHA5 PCDHA3 EIF4G3 | 1.51e-03 | 426 | 260 | 11 | EFO_0007006 |
| Disease | Squamous cell carcinoma of esophagus | 1.55e-03 | 95 | 260 | 5 | C0279626 | |
| Disease | long QT syndrome (is_implicated_in) | 1.58e-03 | 7 | 260 | 2 | DOID:2843 (is_implicated_in) | |
| Disease | Periventricular Nodular Heterotopia | 1.58e-03 | 7 | 260 | 2 | C1868720 | |
| Disease | alcohol consumption measurement | MAGI1 ZHX3 POU6F2 KDM4C CDK12 GPN1 NCKAP5 DCC ZBTB37 PLCB3 IQCE IMPG2 CACNA1E COL12A1 PCLO LYSMD4 SELENON SETBP1 PLXNA4 SENP6 PLCH1 ECE2 | 1.58e-03 | 1242 | 260 | 22 | EFO_0007878 |
| Disease | Colorectal cancer | 1.69e-03 | 27 | 260 | 3 | cv:C0346629 | |
| Disease | Neoplasm of the large intestine | 1.69e-03 | 27 | 260 | 3 | cv:C0009404 | |
| Disease | COLORECTAL CANCER | 1.69e-03 | 27 | 260 | 3 | 114500 | |
| Disease | alkaline phosphatase measurement | ZHX3 MAP1A GATB NT5DC1 KIAA0319 TONSL PKD1 ZBTB40 SERPING1 PRR14L PLEKHH2 MYRF TAT HSPG2 MACF1 SMS EIF4G3 CNOT1 ALPK2 | 1.77e-03 | 1015 | 260 | 19 | EFO_0004533 |
| Disease | fatty acid measurement | ANKRD31 DSCAML1 PLCB3 DOCK6 MYRF DAGLA TIMD4 FAM13C CMIP PLXNA4 MACF1 | 1.81e-03 | 436 | 260 | 11 | EFO_0005110 |
| Disease | mean corpuscular hemoglobin concentration | ZNF131 ZHX3 CDK12 LRRC37A2 FRMD4B FOCAD NEO1 PLCB3 HOOK2 MYRF IMPG2 ITSN1 HECTD4 SLC40A1 TRIM33 MACF1 DOT1L EIF4G3 ATP2B4 ZNF654 | 2.00e-03 | 1105 | 260 | 20 | EFO_0004528 |
| Disease | cerebral infarction (is_implicated_in) | 2.09e-03 | 29 | 260 | 3 | DOID:3526 (is_implicated_in) | |
| Disease | 1,5 anhydroglucitol measurement | 2.09e-03 | 29 | 260 | 3 | EFO_0008009 | |
| Disease | Muscular Dystrophy | 2.09e-03 | 8 | 260 | 2 | C0026850 | |
| Disease | Embryonal Rhabdomyosarcoma | 2.09e-03 | 8 | 260 | 2 | C0206656 | |
| Disease | memory impairment | 2.09e-03 | 8 | 260 | 2 | EFO_0001072 | |
| Disease | holoprosencephaly (is_implicated_in) | 2.09e-03 | 8 | 260 | 2 | DOID:4621 (is_implicated_in) | |
| Disease | Alcohol withdrawal syndrome | 2.09e-03 | 8 | 260 | 2 | C0236663 | |
| Disease | Intellectual Disability | MAP1B ASH1L DCC ZBTB40 TAT CACNA1E APC SETD2 SETBP1 MACF1 ASTN1 | 2.20e-03 | 447 | 260 | 11 | C3714756 |
| Disease | Retinitis Pigmentosa | 2.31e-03 | 104 | 260 | 5 | C0035334 | |
| Disease | Mammary Carcinoma, Human | LRRC37A2 PGR NOP9 LRRC37A NOTCH3 FLNA FN1 SIRT1 SETD2 NISCH SETBP1 FKBPL | 2.58e-03 | 525 | 260 | 12 | C4704874 |
| Disease | Mammary Neoplasms, Human | LRRC37A2 PGR NOP9 LRRC37A NOTCH3 FLNA FN1 SIRT1 SETD2 NISCH SETBP1 FKBPL | 2.58e-03 | 525 | 260 | 12 | C1257931 |
| Disease | Mammary Neoplasms | LRRC37A2 PGR NOP9 LRRC37A NOTCH3 FLNA FN1 SIRT1 SETD2 NISCH SETBP1 FKBPL | 2.66e-03 | 527 | 260 | 12 | C1458155 |
| Disease | Lynch Syndrome | 2.67e-03 | 9 | 260 | 2 | C4552100 | |
| Disease | level of Phosphatidylcholine (O-18:0_20:4) in blood serum | 2.67e-03 | 9 | 260 | 2 | OBA_2045127 | |
| Disease | mitral valve prolapse (is_implicated_in) | 2.67e-03 | 9 | 260 | 2 | DOID:988 (is_implicated_in) | |
| Disease | underweight body mass index status | 2.67e-03 | 9 | 260 | 2 | EFO_0005936 | |
| Disease | choroid plexus volume measurement | 2.67e-03 | 9 | 260 | 2 | EFO_0010293 | |
| Disease | cysteine-rich with EGF-like domain protein 1 measurement | 2.78e-03 | 32 | 260 | 3 | EFO_0021870 | |
| Disease | Ciliopathies | 2.95e-03 | 110 | 260 | 5 | C4277690 | |
| Disease | myocardial infarction (biomarker_via_orthology) | 3.03e-03 | 160 | 260 | 6 | DOID:5844 (biomarker_via_orthology) | |
| Disease | Glioblastoma Multiforme | 3.07e-03 | 111 | 260 | 5 | C1621958 | |
| Disease | obesity (implicated_via_orthology) | 3.08e-03 | 215 | 260 | 7 | DOID:9970 (implicated_via_orthology) | |
| Disease | Endometrioma | 3.12e-03 | 161 | 260 | 6 | C0269102 | |
| Disease | Endometriosis | 3.12e-03 | 161 | 260 | 6 | C0014175 | |
| Disease | Breast Carcinoma | LRRC37A2 PGR NOP9 LRRC37A NOTCH3 FLNA FN1 SIRT1 SETD2 NISCH SETBP1 FKBPL | 3.14e-03 | 538 | 260 | 12 | C0678222 |
| Disease | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 3.26e-03 | 276 | 260 | 8 | EFO_0004612, EFO_0020943 | |
| Disease | vital capacity | IL11 NCOA6 POU6F2 CAND2 ATAD5 CDK12 DCC ZBTB40 PAN2 DAGLA HSPG2 FN1 EPB41L4B PCLO PKDCC PCDHA5 PCDHA3 CMIP DOT1L ANKFN1 NPAS4 | 3.28e-03 | 1236 | 260 | 21 | EFO_0004312 |
| Disease | medulloblastoma (is_implicated_in) | 3.32e-03 | 10 | 260 | 2 | DOID:0050902 (is_implicated_in) | |
| Disease | osteonecrosis (is_implicated_in) | 3.32e-03 | 10 | 260 | 2 | DOID:10159 (is_implicated_in) | |
| Disease | response to carboplatin, response to antineoplastic agent | 3.32e-03 | 10 | 260 | 2 | GO_0097327, GO_0097328 | |
| Disease | age of onset of depressive disorder, wellbeing measurement | 3.32e-03 | 10 | 260 | 2 | EFO_0007869, OBA_2040166 | |
| Disease | Disorders of Intracellular Cobalamin Metabolism | 3.32e-03 | 10 | 260 | 2 | cv:CN043592 | |
| Disease | Kartagener Syndrome | 3.59e-03 | 35 | 260 | 3 | C0022521 | |
| Disease | Ciliary Dyskinesia, Primary, 1, With Or Without Situs Inversus | 3.59e-03 | 35 | 260 | 3 | C4551906 | |
| Disease | Polynesian Bronchiectasis | 3.59e-03 | 35 | 260 | 3 | C4317124 | |
| Disease | cardiomyopathy (implicated_via_orthology) | 3.60e-03 | 71 | 260 | 4 | DOID:0050700 (implicated_via_orthology) | |
| Disease | Adenoma | 3.90e-03 | 36 | 260 | 3 | C0001430 | |
| Disease | Adenoma, Microcystic | 3.90e-03 | 36 | 260 | 3 | C0205648 | |
| Disease | Adenoma, Monomorphic | 3.90e-03 | 36 | 260 | 3 | C0205649 | |
| Disease | Adenoma, Basal Cell | 3.90e-03 | 36 | 260 | 3 | C0205646 | |
| Disease | Follicular adenoma | 3.90e-03 | 36 | 260 | 3 | C0205647 | |
| Disease | Papillary adenoma | 3.90e-03 | 36 | 260 | 3 | C0205650 | |
| Disease | Adenoma, Trabecular | 3.90e-03 | 36 | 260 | 3 | C0205651 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VLPLAEEELPTATLT | 226 | Q7L8C5 | |
| ISEVSLDPIISSNPL | 106 | A8MVM7 | |
| VVTLIESLLSFPSPE | 366 | Q6PI77 | |
| PEALVDSVIAPSRSV | 211 | Q9NXW9 | |
| TAELITVPFDSESPI | 641 | Q96QE3 | |
| SEEPSVSIPFLQTAL | 446 | Q5SW79 | |
| PSDVPLTTTDLAALL | 306 | P59826 | |
| PEESFTTIPDITALE | 221 | Q96KC9 | |
| ELTSLKEATPSPISE | 1176 | Q9NR48 | |
| LPTLLPQVSTTFADE | 556 | Q8NDM7 | |
| ATPVSGISLPDDTLL | 2821 | Q96N23 | |
| AELSLPAAPEITSNE | 3001 | Q96N23 | |
| SSRSLASLVLPEEPV | 361 | Q8NHU2 | |
| PVILPSAEQTTLEAS | 1186 | Q9NYV4 | |
| ELPGDSTLLSPTLET | 251 | Q8WWN8 | |
| PTLETEETSDDLISP | 261 | Q8WWN8 | |
| PLAERTPDTAESLLE | 286 | Q9BXX2 | |
| APSTETELDVLLPTA | 2676 | P13611 | |
| TELDVLLPTATSLPI | 2681 | P13611 | |
| EVLDLSLPPESAATS | 311 | O95503 | |
| ESTSVTVAIPDVDPL | 1066 | Q15878 | |
| PVSIADSEASPLLAV | 136 | Q96Q42 | |
| ETLENISTLVPPTAL | 406 | Q5T601 | |
| VLTLDPETLPAIATT | 186 | Q8WTX7 | |
| VASPEPTDTALTLEN | 776 | Q86TB3 | |
| DPEELSPALVVSSSQ | 1046 | P41180 | |
| VSTTLPQVTEPDIDL | 1901 | Q7Z2Y8 | |
| TTIPEDAPTGTDVLL | 2371 | Q6V0I7 | |
| FVLPASSVESTLPVL | 531 | Q9NWN3 | |
| SDRLASEELPSTAVP | 491 | Q9Y3L3 | |
| PLAERTPDTAESLVE | 286 | Q9BXX3 | |
| AAPLVERTPDTAESL | 306 | Q9BXX3 | |
| PSPDLVSQEATLSEA | 376 | Q8IY22 | |
| ALIPPATTEISADSQ | 986 | Q9P2G1 | |
| AVLESAVVSSPDPIR | 496 | Q6NUN0 | |
| PSSDVISSVELPLDA | 346 | Q5T2E6 | |
| VSESPVTPSALAELL | 441 | O75879 | |
| QPLEITAISSPETSL | 1136 | Q8TEK3 | |
| QTRSSILLAEETPPE | 821 | Q9P1Y5 | |
| ALDEDVPVPSTAISF | 106 | O00305 | |
| RALLPEETPAAVLSS | 946 | Q8IWY9 | |
| IEALPLDTPSSVETD | 571 | Q9UER7 | |
| TLASLALATEPPTES | 896 | P20020 | |
| ASLALATEPPTETLL | 921 | Q01814 | |
| SLALATEPPTESLLL | 896 | Q16720 | |
| ASLALATEPPTESLL | 886 | P23634 | |
| VTSSPDTPAEPVLLE | 956 | O14525 | |
| PLGDTLTVSEAETDP | 271 | Q9NZN5 | |
| EVESLPVASSSTLLP | 381 | Q14494 | |
| STPIIEVEGPLLSDT | 351 | P49116 | |
| TLEASVLVTIEPSSP | 2901 | P98160 | |
| ESASAILPSSAIEDP | 206 | Q9BXF6 | |
| SDDSDDIVIAPSLPT | 676 | Q6IPM2 | |
| EEIAELVASSLPSPL | 141 | Q6IN85 | |
| LSLPSDPLELVVSEA | 406 | Q8N149 | |
| STAILLTPVDPTALL | 81 | Q7Z5J8 | |
| PLPLETSAESLALSE | 3156 | Q01484 | |
| LPEELCEPSSLTLSS | 776 | Q8N7Z5 | |
| PELPAVTSSLELIDL | 391 | Q8NFP4 | |
| DLSVEVNISSETVPP | 426 | Q8NFP4 | |
| DSLEDSVSTSPDPIL | 711 | O75140 | |
| SAEVLSASQTPELPA | 1531 | P51610 | |
| AISLTLPFSSIPVEE | 1931 | Q8WXI7 | |
| SPAEVSILDVTTAPT | 3521 | Q8WXI7 | |
| ISDLDRPTIAPDIST | 5531 | Q8WXI7 | |
| PVIQTLDVSSSEPDT | 10581 | Q8WXI7 | |
| VSSAIPTNISPSELD | 10636 | Q8WXI7 | |
| PSELDALTPLVTISG | 10646 | Q8WXI7 | |
| SLIPVPLTTDTLLSD | 396 | Q504Q3 | |
| VTEDLPPGSTLLTLE | 2491 | Q96JQ0 | |
| SIEAAPSSAAEPVIV | 266 | Q5VV17 | |
| DDITVVTLSDVPSAP | 611 | P43146 | |
| VTTPELLSPVFEELS | 376 | Q86U38 | |
| SLPVLEDSPLSTVIA | 356 | Q9Y5H8 | |
| LDLGLTITPEPTTEV | 611 | O60309 | |
| STIAIPSIEAIAELP | 406 | Q5TFE4 | |
| SPEDAESLSVLSVPS | 1146 | P78559 | |
| IASPLQEDTLSDVAP | 1741 | P46821 | |
| EITQPPLLSISSDSL | 101 | Q9UI95 | |
| DPDDPNTSLVTSVAI | 561 | Q96QZ7 | |
| LLSPSSETTVTVELP | 136 | Q5XG99 | |
| EPLATLSTDVPILSC | 261 | P17735 | |
| LDLGLTITPEPTTEV | 611 | A6NM11 | |
| LDLGLTITPEPTTEV | 611 | A6NMS7 | |
| ADTEIDLFSTDIPPT | 36 | Q6L9T8 | |
| PSAEESPSVELLAEI | 336 | Q5H9T9 | |
| RTSLAPEPSLQEAES | 2321 | Q6PRD1 | |
| APILEVSSPSSDSIL | 116 | Q5VTL7 | |
| TSTPVDNLAAEILPA | 441 | Q96ED9 | |
| TLAPADGPTTDEVTL | 316 | Q76MJ5 | |
| ASETEALPSETRPLV | 66 | Q8N6Q8 | |
| IEDFESSLTRSVPPL | 221 | Q9UBK8 | |
| ISPISILPASTDILE | 286 | Q9NYF5 | |
| SLPTSLERALTEVPD | 316 | P25089 | |
| PLTGLPSSALTVEEL | 21 | Q8WYK2 | |
| VDVDLTPAAPSSESL | 196 | Q12809 | |
| TPAAPSSESLALDEV | 201 | Q12809 | |
| SDTIADLPDPTVVTT | 581 | Q13585 | |
| IVPTEDPSGESLIIS | 91 | Q9UL16 | |
| LLSPLELSDSEPVVV | 396 | P0DPD6 | |
| TDPVSTVTLSLLEPE | 546 | O95382 | |
| TVTLSLLEPETQDIP | 551 | O95382 | |
| LPELPTTLTFIDISN | 206 | Q99645 | |
| SPTALIDSILRESEP | 326 | Q00613 | |
| IDSILRESEPAPASV | 331 | Q00613 | |
| VSPDPRAELDSTVLL | 31 | P20809 | |
| NSPSVTDPTLIADAL | 196 | Q9GZP0 | |
| SSSLGEIPSLIPTDE | 1371 | Q9Y6V0 | |
| PEGPVADTVSTDLLI | 2281 | Q9Y6V0 | |
| DSPLSLPAIVSIAVA | 1231 | Q9HCM2 | |
| DLLASPLSPSEVAAV | 786 | O43157 | |
| EASVPDTIAPGTELL | 1561 | Q9NYQ8 | |
| SSTLIPPLEITVTEE | 1256 | Q9UHC1 | |
| LTITSLFSPVTEDSP | 351 | Q9Y5H3 | |
| PPLSATVTLTVAVAD | 656 | Q9Y5H3 | |
| EVIVTSVSTPLPEDS | 346 | Q9Y5G2 | |
| VSSNIITPISLDDVP | 471 | O60658 | |
| VERISTESPAAPALL | 256 | P15172 | |
| PLADSSVTLSPVDSL | 2091 | Q9UM47 | |
| ETLADIPASPQLLTD | 86 | Q13670 | |
| SVPSISSEADDSIPL | 476 | Q9H3R0 | |
| AAVVATLEEPTSPAA | 1186 | O94854 | |
| LEEPTSSAAAVLTPE | 1251 | O94854 | |
| VQPLDLELSITTEPT | 416 | Q96QE4 | |
| SSDLELRATPEPAQT | 1171 | Q8IWU2 | |
| VPTELSLASITVPLE | 491 | Q9UJY5 | |
| PSPDIIVLSDNEASS | 121 | Q8WXI9 | |
| ADTEIDLFSTDIPPT | 36 | Q5TYM5 | |
| SFPEPDLTVEISESA | 121 | Q9P2E7 | |
| PPLTATATVLVSLVE | 656 | Q9Y5H7 | |
| TPLSDSTPGIIDDIL | 71 | Q96PH6 | |
| SEDEPDTIPTSVLLQ | 2716 | Q9Y4D8 | |
| DSLSPVLHPSDLILT | 311 | Q9HCN4 | |
| ISPLTTLPSEALQTE | 961 | Q8IVE3 | |
| IFLLSPPTETTAELQ | 811 | Q86WI3 | |
| AEPTALPALTTIDLQ | 66 | D6RGH6 | |
| DNPPELIISSLTSSI | 341 | Q9Y5E5 | |
| STEPSEISLSPERLN | 1231 | Q14686 | |
| TSDTLPEVSAIPISL | 41 | P06401 | |
| LIASILSEVAPTPLD | 941 | Q01970 | |
| PSAPELSVVSASEEL | 376 | Q8IUM7 | |
| KATVLPEDIIPSESS | 566 | Q9Y2L6 | |
| EILDSSLPSSIIIGP | 791 | Q9P2D7 | |
| AAPATEESLILPVTS | 196 | Q8NBI3 | |
| TLELEVSPDPASQIL | 46 | Q9UIM3 | |
| PEPSDLQSAVSILAL | 191 | Q9NSI5 | |
| SSSEPTLLLSDPTLV | 206 | Q2UY09 | |
| SSLGVPLTEVVEPLD | 41 | Q96HP0 | |
| PITFSSPADITILLD | 821 | P12109 | |
| LLLSSIEAEVDPPSD | 16 | Q99715 | |
| LEELSLPVPTSDRTT | 196 | Q9BQY9 | |
| LSVTDPAESIPTILD | 216 | Q8TD84 | |
| PSSSEINATTLEDVP | 1076 | Q8TD84 | |
| SETDLSLLTATVVPP | 1976 | P21333 | |
| LDLPSTATSVNIPDL | 766 | P02751 | |
| EELSPLVPVETRASL | 311 | Q8IW35 | |
| SLPIELTSVVPESTE | 71 | Q96JB2 | |
| EEIPTDSSLITPVDR | 1371 | Q8N3K9 | |
| ADTEIDLFSTDIPPT | 36 | H0Y354 | |
| SSTSVDQRLPEEPVL | 321 | Q15811 | |
| NILDLSPFTVTDLTP | 751 | P51795 | |
| EDATILPSPTSETVL | 106 | Q19T08 | |
| LPVSSPVTLDDLAST | 491 | Q5T1N1 | |
| PDISLTLDPSDGSVL | 56 | Q12982 | |
| VEPILEVSSLPTTNS | 56 | P05155 | |
| EPEGTLPAETLLLSS | 411 | Q8NEP3 | |
| AIPEENPSLSSRTEL | 826 | Q9Y4D2 | |
| PEDAPESITRAVASL | 121 | Q9H0L4 | |
| DLLPSLPSSSRTEIE | 926 | Q14289 | |
| SVEFLESPITAVDSP | 216 | A4D161 | |
| TTSTEIELPDVEPAA | 156 | Q9BX70 | |
| PASLVEVSGPVLSEL | 726 | O75155 | |
| AAVLDTEAPTPRLVS | 236 | O75056 | |
| SSLLPETRDQPLSES | 556 | Q9Y267 | |
| SESLTTLQAAPDEAP | 1491 | Q58EX2 | |
| TLQAAPDEAPTILSV | 1496 | Q58EX2 | |
| SRLPETLPSLEEDTL | 261 | P37088 | |
| EIDSITTLPDLTPLF | 186 | O75880 | |
| DEPSLSLDSKPVLVT | 466 | Q9UJQ4 | |
| DLPPDLAEAVGVTTS | 686 | Q9H329 | |
| SETTAIVSIAELPLP | 251 | O43432 | |
| VDSLPLDELPSTVQL | 926 | Q5FWE3 | |
| STSSELVEPLPAEPV | 616 | Q5VV67 | |
| TLQPEEALSTSDPRV | 871 | Q9BXL7 | |
| VPDVLFTTIDLPTDA | 491 | Q86YS7 | |
| FPPILVVLASSESED | 131 | A6NMZ7 | |
| ASVESLLPITAVIPA | 436 | Q5VW36 | |
| STSLLSPLSESPVEE | 626 | Q5VVW2 | |
| ADTEIDLFSTDIPPT | 36 | Q86X60 | |
| PSDPLELVVSGAAET | 411 | Q8N6C8 | |
| VLEPDISAASTPLAS | 466 | Q8WUT4 | |
| ARSVDALDDLTPPST | 491 | Q86X29 | |
| EDDTLVESPAVTPVS | 3626 | P98161 | |
| DEVSETSTLVTPEPL | 241 | Q5THK1 | |
| DSVSLEAEPRSEIPL | 96 | Q8IWE2 | |
| TEPTSPLVELQEIST | 411 | Q9BVI0 | |
| EVDPLVLTALTPDAL | 316 | P0C091 | |
| QPPADLSALSLEEVS | 801 | Q75VX8 | |
| EPVSPQTLAATLAEL | 126 | P30711 | |
| ESILPPSITALSAVA | 3591 | O75445 | |
| VSLDSPEREPILSSE | 81 | O60749 | |
| DLTAVPISTSPEEDS | 276 | P52788 | |
| ETEIPEQLVPISSLS | 101 | Q9NUP7 | |
| SVTAIELIPSVTNPE | 661 | Q9UPN9 | |
| EPEASPSADTTILFV | 76 | P43307 | |
| SPEVEERPAVSLTLD | 1271 | Q9UQ35 | |
| ESASPTIPNLDLLEA | 536 | O75151 | |
| PDTLTTITELGAPVE | 226 | Q504Y2 | |
| ISPDLSQVTLSPELS | 1186 | P12259 | |
| PDLSQVTLSPDISDT | 1431 | P12259 | |
| VTLSPDISDTTLLPD | 1436 | P12259 | |
| PDTTPLRTSEDLINA | 816 | Q969F9 | |
| LDPELSLPETQSRAS | 276 | Q8IYG6 | |
| AVSSEAPLSPTIEEK | 1461 | O14513 | |
| TPSDTESPEVLETQL | 531 | A1L390 | |
| LPVETESQLVTLPSS | 176 | Q8N699 | |
| ATSDSELNEPLLAPV | 36 | P78424 | |
| LSAPSDPLDIVVTGL | 206 | Q14943 | |
| SDLDETRVPEVPSSL | 731 | Q92859 | |
| EALEPSTEPLLTTVE | 271 | Q96LK8 | |
| PPDSSVIVTLLDQAA | 546 | Q96EB6 | |
| SPESVPIISVSLLFA | 446 | Q9NP59 | |
| SPSSILSTLDVELPA | 181 | Q9NZH5 | |
| STPSLIPTIQEEEDS | 436 | Q8NE31 | |
| TKLPPTTISTLLEDE | 816 | Q9BZV3 | |
| QLSPLSVTEDSSAPI | 96 | A4IF30 | |
| RSPPDSESEQLLLET | 341 | Q53GL0 | |
| SNLETPRSESPDLIL | 431 | P0CG40 | |
| SIEVLSTCPSEALIP | 516 | Q8TEV9 | |
| IVEKADSSSVLPSPL | 351 | Q66K14 | |
| PPVLILDEATSALDA | 661 | Q9NP78 | |
| SLSTPEEPTALDILL | 576 | Q8N957 | |
| SLSDLTIESPPNELA | 1656 | P25054 | |
| SSLDAISPVQIDPLA | 701 | A5YKK6 | |
| IPASVLSELLPAEAA | 286 | P50336 | |
| ILAELLSPTPVSTEL | 971 | Q5W0Q7 | |
| AEEPLVSSITRSSEP | 941 | Q9UDY2 | |
| IPVLLSEEDTGSEPS | 1056 | Q5TCY1 | |
| VLDIRELSPPEESTS | 181 | Q5TC79 | |
| VDPLSSVLDGTDPLS | 66 | Q7Z3J2 | |
| LLDTPEGSLALTVPV | 581 | P10745 | |
| VISSAELPSVLPDSA | 961 | O75970 | |
| PTSTPLRDSLLDVVE | 456 | Q14159 | |
| EERPETEPLLSFVAS | 821 | Q9H6E5 | |
| PSLISLDLSANPEIS | 1276 | Q96HA7 | |
| REATSTPEISLEAEP | 21 | P78317 | |
| TAETVAPDNTAIPSL | 31 | Q14515 | |
| TDPSEEPGISTSDIL | 216 | Q8TD17 | |
| PSAASEPTVVLLQAE | 641 | Q9H9D4 | |
| ELEATGPSVPSVILD | 366 | Q9NZV5 | |
| ASTSPGIDIADEIPL | 471 | Q5VX71 | |
| IVEKADSSSVLPSPL | 356 | Q6ZT07 | |
| APAEASTSALVPEET | 1076 | Q9Y2I1 | |
| VDADLVSTVPESATP | 316 | Q06203 | |
| ELLLPTPLSDVDSSS | 691 | Q3MJ13 | |
| ESEILEPSITPVTST | 86 | O75554 | |
| TDTLPAPEVSEAVSL | 276 | Q6ZS81 | |
| SEIEQTPLVSSDPAL | 981 | Q8IZM8 | |
| LPLPSESVDIIISDI | 361 | Q9BTF0 | |
| RSIPEDSELNTVTLP | 386 | Q9GZR1 | |
| LIPTTDEIFLESPTA | 256 | Q5VVX9 | |
| ASLTIPLVPETEDDR | 211 | P13994 | |
| PSPVESLTDSLESNI | 1266 | Q86X10 | |
| SPDLTLEDVIADPTL | 1336 | Q4KWH8 | |
| APLPAVIAESTTVDS | 171 | Q9BYW2 | |
| ETLRDTVAPVVPDLS | 346 | Q13464 | |
| TVAPVVPDLSSDIDT | 351 | Q13464 | |
| DAPRLTLPSVIEADA | 81 | Q96C00 | |
| PLAERTPELVELSSD | 486 | Q9NS56 | |
| TECSDFSPPITVILL | 206 | Q9NXF8 | |
| ATETVTPSEAPVLAA | 301 | Q8NBS9 | |
| TTVAAEAPVLPLSTE | 646 | Q8N1G0 | |
| PSLIALSSEDPILTA | 206 | Q9UL62 | |
| SNVITESLPSAESEP | 151 | P52739 | |
| ITPISAGDLLSPDSV | 386 | Q13769 | |
| LSPLVLEPAASQDTI | 1491 | Q9Y6X0 | |
| VEQSIPESTSTPDLA | 151 | Q9H4I2 | |
| SIIPDTVPSTDLLIE | 776 | Q99959 | |
| PATLVLTSDQSSPEI | 36 | Q13522 | |
| GPILTAESETVLPSD | 221 | Q96H15 | |
| PISLDSDPSLAVSDV | 41 | O94842 | |
| LEERAIPTESITDSP | 306 | Q9UDV7 | |
| IPTESITDSPISAQD | 311 | Q9UDV7 | |
| SVTLETFQDLSLPIP | 496 | Q8TEY7 | |
| APLLPTSLSVEDAAI | 326 | O94874 | |
| PSSVTDVALPALLDS | 526 | Q8NBN3 | |
| EILSIPSETASPEAS | 611 | Q9NUA8 | |
| VLEPEATGESSSLEP | 126 | P78423 | |
| PPVASETVDRLVLES | 281 | Q9BWF2 | |
| PPASLELSSVTVEKS | 276 | Q5VV43 | |
| PGDTETTLLPDDTIT | 1531 | Q9UKN1 | |
| PGDTETTLLPDDTIT | 4171 | Q9UKN1 | |
| EPTLPSAVATEASLD | 1136 | O15069 | |
| ASLLAEPVPSLTSIQ | 1006 | Q9Y2G1 |